<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Michael Vlaicu</title>
	<atom:link href="http://www.straightstocks.com/author/michaelvlaicu/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Tue, 16 Mar 2010 17:10:21 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Copper Stocks Are Under Performing Since February 5th (NYSE:FCX), (NYSE:SCCO), (NYSE:IWM)</title>
		<link>http://www.straightstocks.com/stock-watch/copper-stocks-are-under-performing-since-february-5th-nysefcx-nysescco-nyseiwm/</link>
		<comments>http://www.straightstocks.com/stock-watch/copper-stocks-are-under-performing-since-february-5th-nysefcx-nysescco-nyseiwm/#comments</comments>
		<pubDate>Tue, 16 Mar 2010 08:26:50 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1861</guid>
		<description><![CDATA[Since the February 5th pivot, the stock market has rallied higher. The S#38;P 500 is now approaching its January 2010 high at 1150.00. This recent rally has been lead by the small capitalization stocks in the Russell 2000 index and also the technology heavy NASDAQ Composite. These two indexes have made new highs for 2010.
The [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/copper-stocks-are-under-performing-since-february-5th-nysefcx-nysescco-nyseiwm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Can This Economy Handle $80 Plus Oil? (NYSE:USO), (NYSE:UGA)</title>
		<link>http://www.straightstocks.com/stock-watch/can-this-economy-handle-80-plus-oil-nyseuso-nyseuga/</link>
		<comments>http://www.straightstocks.com/stock-watch/can-this-economy-handle-80-plus-oil-nyseuso-nyseuga/#comments</comments>
		<pubDate>Tue, 16 Mar 2010 08:25:36 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1865</guid>
		<description><![CDATA[Oil made a short term bottom on February 5th, 2010 after hitting an intra-day low price of 69.50. Since that time oil has rallied over 10 points to a high of 82.50 on March 9th, 2010. The continuous gasoline contract on the NYMEX was 1.87 on February 5th and it hit a recent high on [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/can-this-economy-handle-80-plus-oil-nyseuso-nyseuga/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cord Blood America Aims To Be Number One Stem Cell Storage Company In The World (OTC:CBAI)</title>
		<link>http://www.straightstocks.com/stock-watch/cord-blood-america-aims-to-be-number-one-stem-cell-storage-company-in-the-world-otccbai/</link>
		<comments>http://www.straightstocks.com/stock-watch/cord-blood-america-aims-to-be-number-one-stem-cell-storage-company-in-the-world-otccbai/#comments</comments>
		<pubDate>Tue, 16 Mar 2010 08:18:44 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1869</guid>
		<description><![CDATA[Cord Blood America Inc.
(Public, OTC:CBAI)
Sticking to our bread and butter tactic of finding undervalued, high potential stocks on the verge of a rebound, we are shining the spotlight on Cord Blood America (OTC:CBAI) which aims to break though as a world-wide top player within the stem cell storage industry. Initially drawn by the chart, we [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cord-blood-america-aims-to-be-number-one-stem-cell-storage-company-in-the-world-otccbai/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Newport Digital Technologies Set To Generate First Time Revenues (OTC:NPDT)</title>
		<link>http://www.straightstocks.com/stock-watch/newport-digital-technologies-set-to-generate-first-time-revenues-otcnpdt/</link>
		<comments>http://www.straightstocks.com/stock-watch/newport-digital-technologies-set-to-generate-first-time-revenues-otcnpdt/#comments</comments>
		<pubDate>Tue, 09 Mar 2010 13:40:49 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Development Stage Company]]></category>
		<category><![CDATA[Digital Signage]]></category>
		<category><![CDATA[hawk eye]]></category>
		<category><![CDATA[industrial technology research]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Radio Frequency Identification]]></category>
		<category><![CDATA[signage solution]]></category>
		<category><![CDATA[taiwan industry]]></category>
		<category><![CDATA[technology research institute]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1854</guid>
		<description><![CDATA[Newport Digital Technologies, Inc.
(Public,  OTC:NPDT)
To get this out of the way right off the bat, Newport Digital is a development stage company, and has yet to realize revenues in its  redirected business. However, this is all to change with their recent piece of news: Newport Digital Technologies introduces wireless LED digital signage solution. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/newport-digital-technologies-set-to-generate-first-time-revenues-otcnpdt/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Coal Plays On Fire Triggering My Love For National Coal Corp. (NASDAQ:NCOC), (NYSE:PCX), (AMEX:PUDA)</title>
		<link>http://www.straightstocks.com/stock-watch/coal-plays-on-fire-triggering-my-love-for-national-coal-corp-nasdaqncoc-nysepcx-amexpuda/</link>
		<comments>http://www.straightstocks.com/stock-watch/coal-plays-on-fire-triggering-my-love-for-national-coal-corp-nasdaqncoc-nysepcx-amexpuda/#comments</comments>
		<pubDate>Tue, 09 Mar 2010 05:22:35 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analytics]]></category>
		<category><![CDATA[chief market strategist]]></category>
		<category><![CDATA[coal]]></category>
		<category><![CDATA[Coal Stocks]]></category>
		<category><![CDATA[Commodity Stocks]]></category>
		<category><![CDATA[Gareth Soloway;]]></category>
		<category><![CDATA[James River]]></category>
		<category><![CDATA[James River Coal Company;]]></category>
		<category><![CDATA[Ltd.;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[national coal]]></category>
		<category><![CDATA[Puda]]></category>
		<category><![CDATA[Puda Coal Inc.;]]></category>
		<category><![CDATA[RealTick]]></category>
		<category><![CDATA[Townsend]]></category>
		<category><![CDATA[townsend analytics]]></category>
		<category><![CDATA[U.S. Economy]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[world commodity prices]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1843</guid>
		<description><![CDATA[Commodity stocks have been ripping of late.  After the Jobs Report on Friday, the U.S Economy seems to be on the path to a solid recovery or so it may seem to most.  Positive comments have emerged on many sectors from steel to coal.  With analysts seeing a recovery not only in the United States [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/coal-plays-on-fire-triggering-my-love-for-national-coal-corp-nasdaqncoc-nysepcx-amexpuda/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Decision Expected Soon For ParaMax, Paradigm Medical (OTC:PDMI)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-decision-expected-soon-for-paramax-paradigm-medical-otcpdmi-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-decision-expected-soon-for-paramax-paradigm-medical-otcpdmi-2/#comments</comments>
		<pubDate>Tue, 09 Mar 2010 05:20:38 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[causes of blindness]]></category>
		<category><![CDATA[corneal curvature]]></category>
		<category><![CDATA[corneal topographer]]></category>
		<category><![CDATA[glaucoma detection]]></category>
		<category><![CDATA[leading causes of blindness]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[paradigm medical industries]]></category>
		<category><![CDATA[Paradigm Medical Industries Inc.;]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1850</guid>
		<description><![CDATA[The FDA decision on Paradigm Medical Industries, Inc. (OTC: PDMI)  lead device candidate ParaMax for Glaucoma early detection is expecting  anytime soon.
ParaMax device for early Glaucoma detection is awaiting FDA approval.
Paradigm#8217;s (OTC: PDMI) has recently announced that his Italian partner CSO (Costruzione Strumenti Oftalmici) has completed  and submitted all necessary documents to the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-decision-expected-soon-for-paramax-paradigm-medical-otcpdmi-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Decision Expected Soon For ParaMax, Paradigm Medical (OTC:PDMI)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-decision-expected-soon-for-paramax-paradigm-medical-otcpdmi/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-decision-expected-soon-for-paramax-paradigm-medical-otcpdmi/#comments</comments>
		<pubDate>Mon, 08 Mar 2010 04:14:51 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[corneal curvature]]></category>
		<category><![CDATA[corneal surface]]></category>
		<category><![CDATA[corneal topographer]]></category>
		<category><![CDATA[corneal topography]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[fda decision]]></category>
		<category><![CDATA[glaucoma]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mr. Davis]]></category>
		<category><![CDATA[paradigm medical industries]]></category>
		<category><![CDATA[Paradigm Medical Industries Inc.;]]></category>
		<category><![CDATA[Paradigm;]]></category>
		<category><![CDATA[paramax]]></category>
		<category><![CDATA[Salt Lake City]]></category>
		<category><![CDATA[Stephen]]></category>
		<category><![CDATA[Steve Davis]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[Utah]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1832</guid>
		<description><![CDATA[The FDA decision on Paradigm Medical Industries, Inc. (OTC: PDMI) lead device candidate ParaMax for Glaucoma early detection is expecting anytime soon.
Paradigm team has been very busy these last months, preparing the release of fantastic new devices, auditing in regards to the FDA visit of their facility, all the while continuing talks of securing a [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-decision-expected-soon-for-paramax-paradigm-medical-otcpdmi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Analysis Video On Copper King Mining (PINK:CPRK)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-analysis-video-on-copper-king-mining-pinkcprk/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-analysis-video-on-copper-king-mining-pinkcprk/#comments</comments>
		<pubDate>Mon, 08 Mar 2010 01:02:38 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[beaver county utah]]></category>
		<category><![CDATA[copper company]]></category>
		<category><![CDATA[copper king]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[milford utah]]></category>
		<category><![CDATA[mineral belt]]></category>
		<category><![CDATA[Pink Sheets]]></category>
		<category><![CDATA[Precious Metals]]></category>
		<category><![CDATA[utah region]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1829</guid>
		<description><![CDATA[Copper King Mining Corporation
(Public, PINK:CPRK)
With the recent success of Copper King Mining Corporation (PINK: CPRK), a technical video analysis was conducted in order to update expectations on what is likely to happen in the coming days. Our conference call was a tremendous success and nabbed quite a few details on the company#8217;s current and future [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-analysis-video-on-copper-king-mining-pinkcprk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Analysis Update On Copper King Mining (PINK:CPRK)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk-3/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk-3/#comments</comments>
		<pubDate>Sat, 06 Mar 2010 23:11:20 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Beaver]]></category>
		<category><![CDATA[beaver county utah]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Copper]]></category>
		<category><![CDATA[copper company]]></category>
		<category><![CDATA[copper king]]></category>
		<category><![CDATA[CPRK]]></category>
		<category><![CDATA[Day;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Milford]]></category>
		<category><![CDATA[milford utah]]></category>
		<category><![CDATA[mineral belt]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[Pink Sheets]]></category>
		<category><![CDATA[Precious Metals]]></category>
		<category><![CDATA[Price;]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[utah region]]></category>
		<category><![CDATA[Western Utah]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1823</guid>
		<description><![CDATA[Copper King Mining Corporation
(Public, PINK:CPRK)
With the recent success of Copper King Mining Corporation (PINK: CPRK), a technical video analysis was conducted in order to update expectations on what is likely to happen in the coming days. Our conference call was a tremendous success and nabbed quite a few details on the company#8217;s current and future [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Analysis Update On Copper King Mining (PINK:CPRK)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk-2/#comments</comments>
		<pubDate>Sat, 06 Mar 2010 14:17:32 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Beaver]]></category>
		<category><![CDATA[beaver county utah]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Copper]]></category>
		<category><![CDATA[copper company]]></category>
		<category><![CDATA[copper king]]></category>
		<category><![CDATA[CPRK]]></category>
		<category><![CDATA[Day;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Milford]]></category>
		<category><![CDATA[milford utah]]></category>
		<category><![CDATA[mineral belt]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[Pink Sheets]]></category>
		<category><![CDATA[Precious Metals]]></category>
		<category><![CDATA[Price;]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[utah region]]></category>
		<category><![CDATA[Western Utah]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1817</guid>
		<description><![CDATA[Copper King Mining Corporation
(Public, PINK:CPRK)
With the recent success of Copper King Mining Corporation (PINK: CPRK), a technical video analysis was conducted in order to update expectations on what is likely to happen in the coming days. Our conference call was a tremendous success and nabbed quite a few details on the company#8217;s current and future [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Analysis Update On Copper King Mining (PINK:CPRK)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk/#comments</comments>
		<pubDate>Fri, 05 Mar 2010 22:02:49 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Beaver]]></category>
		<category><![CDATA[beaver county utah]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Copper]]></category>
		<category><![CDATA[copper company]]></category>
		<category><![CDATA[copper king]]></category>
		<category><![CDATA[Day;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Milford]]></category>
		<category><![CDATA[milford utah]]></category>
		<category><![CDATA[mineral belt]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[Pink Sheets]]></category>
		<category><![CDATA[Precious Metals]]></category>
		<category><![CDATA[Price;]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[utah region]]></category>
		<category><![CDATA[Western Utah]]></category>
		<category><![CDATA[White]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1810</guid>
		<description><![CDATA[With the recent success of Copper King Mining Corporation (PINK: CPRK), a technical video analysis was conducted in order to update expectations on what is likely to happen in the coming days. Our conference call was a tremendous success and nabbed quite a few details on the company#8217;s current and future business operations, we highly [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-analysis-update-on-copper-king-mining-pinkcprk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Markets Hover Flat As Scary Pattern Looms. (NYSE:ANF), (NYSE:FDO), (NYSE:WMT), (NYSE:SPY)</title>
		<link>http://www.straightstocks.com/stock-watch/markets-hover-flat-as-scary-pattern-looms-nyseanf-nysefdo-nysewmt-nysespy/</link>
		<comments>http://www.straightstocks.com/stock-watch/markets-hover-flat-as-scary-pattern-looms-nyseanf-nysefdo-nysewmt-nysespy/#comments</comments>
		<pubDate>Thu, 04 Mar 2010 20:55:48 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Dividend Stocks]]></category>
		<category><![CDATA[Family Dollar Stores]]></category>
		<category><![CDATA[Family Dollar Stores Inc.]]></category>
		<category><![CDATA[first time home buyer]]></category>
		<category><![CDATA[Gareth Soloway;]]></category>
		<category><![CDATA[Inthemoneystocks]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[SPY]]></category>
		<category><![CDATA[time home buyer]]></category>
		<category><![CDATA[Today]]></category>
		<category><![CDATA[U.S. Dollar]]></category>
		<category><![CDATA[Wal Mart Stores]]></category>
		<category><![CDATA[Wal Mart Stores Inc]]></category>
		<category><![CDATA[weather problems]]></category>
		<category><![CDATA[week]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1800</guid>
		<description><![CDATA[The markets initially rallied today on the back of great retail sales numbers and an announcement that Wal-Mart Stores, Inc. (NYSE:WMT) raised its dividend.  Stocks like Abercrombie #38; Fitch Co. (NYSE:ANF), Family Dollar Stores, Inc. (NYSE:FDO) are soaring today as sales numbers, expected to be poor because of all the snow and weather problems, were [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/markets-hover-flat-as-scary-pattern-looms-nyseanf-nysefdo-nysewmt-nysespy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Copper King (PINK:CPRK) Moves Towards Transparency and Discusses Upgrades and Restart of Mill</title>
		<link>http://www.straightstocks.com/stock-watch/copper-king-pinkcprk-moves-towards-transparency-and-discusses-upgrades-and-restart-of-mill/</link>
		<comments>http://www.straightstocks.com/stock-watch/copper-king-pinkcprk-moves-towards-transparency-and-discusses-upgrades-and-restart-of-mill/#comments</comments>
		<pubDate>Thu, 04 Mar 2010 07:20:00 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Beaver]]></category>
		<category><![CDATA[Chile]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Copper]]></category>
		<category><![CDATA[copper king]]></category>
		<category><![CDATA[Corp]]></category>
		<category><![CDATA[CPRK]]></category>
		<category><![CDATA[earthquake in chile]]></category>
		<category><![CDATA[experiencing technical difficulties]]></category>
		<category><![CDATA[king]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Milford]]></category>
		<category><![CDATA[mineral belt]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[mining corp]]></category>
		<category><![CDATA[Mr. Charles A. Moskowitz]]></category>
		<category><![CDATA[news wires]]></category>
		<category><![CDATA[Pink Sheets]]></category>
		<category><![CDATA[Shareholder Value]]></category>
		<category><![CDATA[stock buyback]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[Western Utah]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1787</guid>
		<description><![CDATA[Copper King Mining Corp.
(Public, PINK:CPRK)
Interestingly enough, we stumbled upon Copper King Mining (PINK:CPRK) while looking for a play during the earthquake in Chile which swept through the news-wires. Little did we know at the time the treasure we had uncovered, a company which for the first time in years could finally pick up some steam [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/copper-king-pinkcprk-moves-towards-transparency-and-discusses-upgrades-and-restart-of-mill/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Systems Evolution (PINK:SSEV) On The Verge Of A Major Rebound</title>
		<link>http://www.straightstocks.com/stock-watch/systems-evolution-pinkssev-on-the-verge-of-a-major-rebound/</link>
		<comments>http://www.straightstocks.com/stock-watch/systems-evolution-pinkssev-on-the-verge-of-a-major-rebound/#comments</comments>
		<pubDate>Thu, 04 Mar 2010 02:33:27 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[disclosure statement]]></category>
		<category><![CDATA[Down Trend]]></category>
		<category><![CDATA[Evolution]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[informational pieces]]></category>
		<category><![CDATA[investments inc]]></category>
		<category><![CDATA[MedDorna]]></category>
		<category><![CDATA[Mel Robinson]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[network]]></category>
		<category><![CDATA[pilot test]]></category>
		<category><![CDATA[San Antonio]]></category>
		<category><![CDATA[state deals]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[Support;]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[ultimate risk]]></category>
		<category><![CDATA[Warren Buffet]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1773</guid>
		<description><![CDATA[Systems Evolution, Inc.
(Public, OTC:SSEV.PK)
Systems Evolution, Inc. has seen some major action lately from the small cap crowd, and now the question becomes, can it last? MIV Investments Inc. has devised a fair amount of time researching this company, which has seen its shares drop significantly over the past several months. There has been a down-trend [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/systems-evolution-pinkssev-on-the-verge-of-a-major-rebound/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Most Talked About Small Cap Stocks On The Net: Health Sciences, GoIP Global, Spongetech, Indocan Resources, Cape Systems</title>
		<link>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-health-sciences-goip-global-spongetech-indocan-resources-cape-systems/</link>
		<comments>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-health-sciences-goip-global-spongetech-indocan-resources-cape-systems/#comments</comments>
		<pubDate>Wed, 03 Mar 2010 08:26:32 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Ambassador Program]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Ernst]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[go800]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[Health Sciences Group]]></category>
		<category><![CDATA[Health Sciences Group Inc.]]></category>
		<category><![CDATA[hesg]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[indocan resources]]></category>
		<category><![CDATA[James Reilly]]></category>
		<category><![CDATA[Licensing]]></category>
		<category><![CDATA[Livingston County]]></category>
		<category><![CDATA[medical marijuana patients]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Montana]]></category>
		<category><![CDATA[Mr. Ike Sutton]]></category>
		<category><![CDATA[Pink]]></category>
		<category><![CDATA[small cap companies]]></category>
		<category><![CDATA[SpongeTech]]></category>
		<category><![CDATA[Systems Group Inc]]></category>
		<category><![CDATA[U. S. Securities]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1766</guid>
		<description><![CDATA[Below is a list of the small cap companies that have been making waves accross some of the world#8217;s most popular stock market forums for Wednesday, March, 3, 2010. Yahoo, Google, Investorshub, TheLion, and a few others were taken into consideration.
News Updates for: Health Sciences Group (OTC:HESG), GoIP Global, Inc. (PINK:GOIG), Spongetech Dlivery Systems, Inc. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-health-sciences-goip-global-spongetech-indocan-resources-cape-systems/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Watchlist: Updates for Cardium, AstraZeneca, Amylin, Osteotech</title>
		<link>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-cardium-astrazeneca-amylin-osteotech/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-cardium-astrazeneca-amylin-osteotech/#comments</comments>
		<pubDate>Wed, 03 Mar 2010 04:31:53 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Amylin Pharmaceuticals;]]></category>
		<category><![CDATA[Azn]]></category>
		<category><![CDATA[Cardium]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[collagen protein]]></category>
		<category><![CDATA[CXM]]></category>
		<category><![CDATA[diabetic foot ulcers]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[low dose aspirin]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Osteotech Inc]]></category>
		<category><![CDATA[surgical debridement]]></category>
		<category><![CDATA[trauma wounds]]></category>
		<category><![CDATA[use]]></category>
		<category><![CDATA[wound care management]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1761</guid>
		<description><![CDATA[Updates for: Cardium Therapeutics (AMEX:CXM), AstraZeneca plc (ADR) (NYSE:AZN), Amylin Pharmaceuticals (NASDAQ:AMLN), and Osteotech, Inc. (NASDAQ:OSTE)
Cardium Therapeutics Inc.
(AMEX:CXM)

On 12/3/09, Cardium (CXM) announced that its wholly-owned subsidiary (Tissue Repair Company) submitted a 510(k) premarket notification filing with the FDA seeking marketing clearance of its Excellagen product candidate. The 510k submission covers ExcellagenXL and ExcellagenFX, advanced wound [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-cardium-astrazeneca-amylin-osteotech/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Amazon (NasdaqGS: AMZN) Jumps Towards The 50MA</title>
		<link>http://www.straightstocks.com/stock-watch/amazon-nasdaqgs-amzn-jumps-towards-the-50ma/</link>
		<comments>http://www.straightstocks.com/stock-watch/amazon-nasdaqgs-amzn-jumps-towards-the-50ma/#comments</comments>
		<pubDate>Tue, 02 Mar 2010 16:57:00 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[chief market strategist]]></category>
		<category><![CDATA[com]]></category>
		<category><![CDATA[Day;]]></category>
		<category><![CDATA[England]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Gareth Soloway;]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[Goldman Sachs Group Inc]]></category>
		<category><![CDATA[Greece]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[nyse jpm]]></category>
		<category><![CDATA[pound]]></category>
		<category><![CDATA[Sachs Group Inc]]></category>
		<category><![CDATA[SanDisk Corporation]]></category>
		<category><![CDATA[semiconductor sector]]></category>
		<category><![CDATA[Today]]></category>
		<category><![CDATA[Townsend]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1746</guid>
		<description><![CDATA[Amazon.com, Inc. (NasdaqGS: AMZN) soared all day as it approached the daily 50 moving average.  This level is at approximately $125.25 and should be short term resistance.  The whole tech sector rallied today on the back of positive comments about the semiconductor sector.  SanDisk Corporation (NASDAQ:SNDK) jumped almost 12% on good news and analyst comments.  [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/amazon-nasdaqgs-amzn-jumps-towards-the-50ma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bederra Corporation Touted One Of The Most Undervalued Stocks By Analysts</title>
		<link>http://www.straightstocks.com/stock-watch/bederra-corporation-touted-one-of-the-most-undervalued-stocks-by-analysts/</link>
		<comments>http://www.straightstocks.com/stock-watch/bederra-corporation-touted-one-of-the-most-undervalued-stocks-by-analysts/#comments</comments>
		<pubDate>Tue, 02 Mar 2010 16:55:04 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[4 Months]]></category>
		<category><![CDATA[applicable link]]></category>
		<category><![CDATA[BEDA]]></category>
		<category><![CDATA[business objectives]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[FINRA]]></category>
		<category><![CDATA[float]]></category>
		<category><![CDATA[Investment Community]]></category>
		<category><![CDATA[List]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Naked]]></category>
		<category><![CDATA[Naked Shorting]]></category>
		<category><![CDATA[news wires]]></category>
		<category><![CDATA[private investor]]></category>
		<category><![CDATA[Reg SHO]]></category>
		<category><![CDATA[Spreadsheets]]></category>
		<category><![CDATA[trading]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1749</guid>
		<description><![CDATA[Bederra Corp.
(Public, PINK:BEDA)
After naming this one of our top picks of 2010, we had to follow up and dig deeper around the investment community to find further research which truly exposes the undiscovered potential value which could be in play here during the next few weeks. Below you will find proof on one of the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bederra-corporation-touted-one-of-the-most-undervalued-stocks-by-analysts/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>The Money Play Is Palm.  (NASDAQ:PALM)</title>
		<link>http://www.straightstocks.com/stock-watch/the-money-play-is-palm-nasdaqpalm/</link>
		<comments>http://www.straightstocks.com/stock-watch/the-money-play-is-palm-nasdaqpalm/#comments</comments>
		<pubDate>Sat, 27 Feb 2010 04:50:27 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Capitulation]]></category>
		<category><![CDATA[chief market strategist]]></category>
		<category><![CDATA[dramatic fall]]></category>
		<category><![CDATA[Gareth Soloway;]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[massive support]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[PALM]]></category>
		<category><![CDATA[Palm Inc]]></category>
		<category><![CDATA[Price;]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[stock action]]></category>
		<category><![CDATA[Stock Price]]></category>
		<category><![CDATA[term]]></category>
		<category><![CDATA[Today]]></category>
		<category><![CDATA[townsend analytics]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Wall Street]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1740</guid>
		<description><![CDATA[Palm, Inc. (NASDAQ:PALM) has been under intense sell pressure since the January 9th, 2010 high was made at $14.17.  Since that point, the stock price has fallen to a low today of $6.07.  This is just slightly off the 52 week low of $5.85.  The 5 week dramatic fall in Palm, Inc. culminated with a warning yest]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/the-money-play-is-palm-nasdaqpalm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bederra Rebounds On News Of Newly Implemented Short-Selling Restrictions</title>
		<link>http://www.straightstocks.com/stock-watch/bederra-rebounds-on-news-of-newly-implemented-short-selling-restrictions/</link>
		<comments>http://www.straightstocks.com/stock-watch/bederra-rebounds-on-news-of-newly-implemented-short-selling-restrictions/#comments</comments>
		<pubDate>Fri, 26 Feb 2010 08:18:15 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[backtrack]]></category>
		<category><![CDATA[Bederra]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[free shares]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[imaging]]></category>
		<category><![CDATA[Individual Investors]]></category>
		<category><![CDATA[inequities]]></category>
		<category><![CDATA[Insurance]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nice]]></category>
		<category><![CDATA[pet]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[rule 10a]]></category>
		<category><![CDATA[Stock Exchanges]]></category>
		<category><![CDATA[Stock Price]]></category>
		<category><![CDATA[uptick rule]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1713</guid>
		<description><![CDATA[Bederra Corp.
(Public, PINK:BEDA)
Nothing has had more financial buzz lately than the announcement of the newly re-established #8220;uptick light#8221; , of which the SEC voted on in order to enlist a temporary ban on short selling, and quite frankly, it couldn#8217;t have come at a better time.  With the recent collapse of the financial markets leading [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bederra-rebounds-on-news-of-newly-implemented-short-selling-restrictions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Deja vu from February 2007 (NYSE:SPY), (NYSE:DIA)</title>
		<link>http://www.straightstocks.com/stock-watch/deja-vu-from-february-2007-nysespy-nysedia/</link>
		<comments>http://www.straightstocks.com/stock-watch/deja-vu-from-february-2007-nysespy-nysedia/#comments</comments>
		<pubDate>Thu, 25 Feb 2010 18:25:08 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[Debt]]></category>
		<category><![CDATA[Diamonds Trust]]></category>
		<category><![CDATA[Dow Jones Industrial]]></category>
		<category><![CDATA[Dow Jones Industrial Average]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fed Funds Rate]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Greece]]></category>
		<category><![CDATA[Iceland]]></category>
		<category><![CDATA[International Monetary Fund]]></category>
		<category><![CDATA[International Monetary Fund Imf]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nicholas Santiago;]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[point decline]]></category>
		<category><![CDATA[SPDR Trust]]></category>
		<category><![CDATA[TIME;]]></category>
		<category><![CDATA[trust]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1712</guid>
		<description><![CDATA[Many traders and investors will remember the crash on February 27th, 2007. Back then at that time the market declined as the sub prime crisis began to surface and many countries including Iceland had huge exposure to these toxic assets. On that day the SPDR Trust (NYSE:SPY) declined about 5 points, which is equal to [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/deja-vu-from-february-2007-nysespy-nysedia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Economic News Shocks But Gives Forth Opportunity. (NASDAQ:FSLR), (NASDAQ:QCOM), (NYSE:UUP)</title>
		<link>http://www.straightstocks.com/stock-watch/economic-news-shocks-but-gives-forth-opportunity-nasdaqfslr-nasdaqqcom-nyseuup/</link>
		<comments>http://www.straightstocks.com/stock-watch/economic-news-shocks-but-gives-forth-opportunity-nasdaqfslr-nasdaqqcom-nyseuup/#comments</comments>
		<pubDate>Thu, 25 Feb 2010 18:22:54 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Bounce]]></category>
		<category><![CDATA[Chart;]]></category>
		<category><![CDATA[consumer confidence]]></category>
		<category><![CDATA[Dividend Yield]]></category>
		<category><![CDATA[dramatic fashion]]></category>
		<category><![CDATA[Exxon Mobil]]></category>
		<category><![CDATA[Exxon Mobil Corporation]]></category>
		<category><![CDATA[February]]></category>
		<category><![CDATA[Gareth Soloway;]]></category>
		<category><![CDATA[level]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[Swing Trades]]></category>
		<category><![CDATA[Today]]></category>
		<category><![CDATA[Verizon Communications]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[wall street]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1711</guid>
		<description><![CDATA[The markets continue to get hammered today with the DOW lower by 1.65%, Nasdaq down 1.40% and the S#38;P 500 dropping 1.50%.  This is all on the back of economic data released over the last three days that has stunned Wall Street.  Consumer Confidence shocked, New Home Sales jolted and today, Jobless Claims [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/economic-news-shocks-but-gives-forth-opportunity-nasdaqfslr-nasdaqqcom-nyseuup/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top 3 Setups For Legendary Swings. (NYSE:XOM), (NYSE:VZ), (NASDAQ:CNLG), (NYSE:T)</title>
		<link>http://www.straightstocks.com/stock-watch/top-3-setups-for-legendary-swings-nysexom-nysevz-nasdaqcnlg-nyset/</link>
		<comments>http://www.straightstocks.com/stock-watch/top-3-setups-for-legendary-swings-nysexom-nysevz-nasdaqcnlg-nyset/#comments</comments>
		<pubDate>Thu, 25 Feb 2010 17:09:28 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Bounce]]></category>
		<category><![CDATA[Chart;]]></category>
		<category><![CDATA[consumer confidence]]></category>
		<category><![CDATA[Dividend Yield]]></category>
		<category><![CDATA[dramatic fashion]]></category>
		<category><![CDATA[Exxon Mobil]]></category>
		<category><![CDATA[Exxon Mobil Corporation]]></category>
		<category><![CDATA[February]]></category>
		<category><![CDATA[Gareth Soloway;]]></category>
		<category><![CDATA[level]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[Swing Trades]]></category>
		<category><![CDATA[Today]]></category>
		<category><![CDATA[Verizon Communications]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[wall street]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1710</guid>
		<description><![CDATA[The markets continue to get hammered today with the DOW lower by 1.65%, Nasdaq down 1.40% and the S#38;P 500 dropping 1.50%.  This is all on the back of economic data released over the last three days that has stunned Wall Street.  Consumer Confidence shocked, New Home Sales jolted and today, Jobless Claims [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/top-3-setups-for-legendary-swings-nysexom-nysevz-nasdaqcnlg-nyset/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The South Financial Group On The Brink Of Recovery</title>
		<link>http://www.straightstocks.com/stock-watch/the-south-financial-group-on-the-brink-of-recovery/</link>
		<comments>http://www.straightstocks.com/stock-watch/the-south-financial-group-on-the-brink-of-recovery/#comments</comments>
		<pubDate>Mon, 22 Feb 2010 08:29:30 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[clean coal technologies]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Financial Group Inc]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Greenville]]></category>
		<category><![CDATA[Greenwich Associates]]></category>
		<category><![CDATA[Group;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nasdaq]]></category>
		<category><![CDATA[nasdaq delisting]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[Price Target]]></category>
		<category><![CDATA[Small Business Banking]]></category>
		<category><![CDATA[South Carolina]]></category>
		<category><![CDATA[South Financial Group]]></category>
		<category><![CDATA[south financial group inc]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[TSFG]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1695</guid>
		<description><![CDATA[The South Financial Group Inc.
(Public, NASDAQ:TSFG)
Bottom plays have become a specialty of ours, especially after our latest alert on Clean Coal Technologies (PINK: CCTC) which had major success bringing in more than 300% return on investment for our readers, thus we are launching our new candidate in The South Financial Group Inc. (NASDAQ: TSFG). This [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/the-south-financial-group-on-the-brink-of-recovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clean Coal Technologies: On The Verge Of A Major Rebound</title>
		<link>http://www.straightstocks.com/stock-watch/clean-coal-technologies-on-the-verge-of-a-major-rebound/</link>
		<comments>http://www.straightstocks.com/stock-watch/clean-coal-technologies-on-the-verge-of-a-major-rebound/#comments</comments>
		<pubDate>Thu, 18 Feb 2010 07:40:06 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[balanced management]]></category>
		<category><![CDATA[carbon]]></category>
		<category><![CDATA[CCTC]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[clean coal technologies]]></category>
		<category><![CDATA[coal]]></category>
		<category><![CDATA[dioxide]]></category>
		<category><![CDATA[Gold]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[molten lava]]></category>
		<category><![CDATA[Pink Sheet Stocks]]></category>
		<category><![CDATA[Platinum]]></category>
		<category><![CDATA[Price Target]]></category>
		<category><![CDATA[small cap stock]]></category>
		<category><![CDATA[stock fall]]></category>
		<category><![CDATA[tasty stew]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[USA]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1670</guid>
		<description><![CDATA[Clean Coal Technologies, Inc.
(Public, PINK:CCTC)

Coal is by far the dirtiest way America makes power, however, a revolution is taking place in this old industry by the way of #8220;Clean Coal#8221;, leaving up and coming companies poised for major growth in the near future. Welcome to Clean Coal Technologies (PINK:CCTC). Yes folks, if you#8217;ve picked up [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/clean-coal-technologies-on-the-verge-of-a-major-rebound/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Future Of Medicine, Personalization Using DNA</title>
		<link>http://www.straightstocks.com/stock-watch/the-future-of-medicine-personalization-using-dna/</link>
		<comments>http://www.straightstocks.com/stock-watch/the-future-of-medicine-personalization-using-dna/#comments</comments>
		<pubDate>Wed, 17 Feb 2010 08:37:09 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[dna collection]]></category>
		<category><![CDATA[Gene;]]></category>
		<category><![CDATA[GeneLink]]></category>
		<category><![CDATA[genelink inc]]></category>
		<category><![CDATA[Growth]]></category>
		<category><![CDATA[human dna]]></category>
		<category><![CDATA[human genome project]]></category>
		<category><![CDATA[human genome project hgp]]></category>
		<category><![CDATA[life sciences inc]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[monster company]]></category>
		<category><![CDATA[Monte Taylor]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[revenue]]></category>
		<category><![CDATA[Target Market]]></category>
		<category><![CDATA[way]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1651</guid>
		<description><![CDATA[GeneLink Inc.
(Public, OTC:GNLK)
First and foremost lets get some things out of the way as we know most of you have been awaiting this company profile for quite some time. We have been busy as a team upgrading the website on all fronts, and this weekend was no exception to the fact, however, unforeseen events causing [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/the-future-of-medicine-personalization-using-dna/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Most Talked About Small Cap Stocks On The Net: Cascadia (PINK:CDIV), Washington (OTC:WAMUQ), Muscle Flex (OTC:MFLI), Pop N Go (OTC:POPN)</title>
		<link>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-cascadia-pinkcdiv-washington-otcwamuq-muscle-flex-otcmfli-pop-n-go-otcpopn-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-cascadia-pinkcdiv-washington-otcwamuq-muscle-flex-otcmfli-pop-n-go-otcpopn-2/#comments</comments>
		<pubDate>Thu, 11 Feb 2010 15:04:25 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[adoptme]]></category>
		<category><![CDATA[Cascadia]]></category>
		<category><![CDATA[CDIV]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[internet development company]]></category>
		<category><![CDATA[Investments]]></category>
		<category><![CDATA[investments inc]]></category>
		<category><![CDATA[media initiative]]></category>
		<category><![CDATA[mfli]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[mutual]]></category>
		<category><![CDATA[N Go]]></category>
		<category><![CDATA[Otc]]></category>
		<category><![CDATA[Pacific]]></category>
		<category><![CDATA[small cap companies]]></category>
		<category><![CDATA[Term Earnings]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington Mutual Inc]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1636</guid>
		<description><![CDATA[Below is a list of the small cap companies that have been making waves accross some of the world#8217;s most popular stock market forums for Thursday, February 11, 2010. Yahoo, Google, Investorshub, TheLion, and a few others were taken into consideration.
News Updates for: Cascadia Investments (PINK:CDIV), Washington Mutual (OTC:WAMUQ), Muscle Flex, Inc. (OTC:MFLI), and Pop [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-cascadia-pinkcdiv-washington-otcwamuq-muscle-flex-otcmfli-pop-n-go-otcpopn-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Most Talked About Small Cap Stocks On The Net: Cascadia (PINK:CDIV), Washington (OTC:WAMUQ), Muscle Flex (OTC:MFLI), Pop N Go (OTC:POPN)</title>
		<link>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-cascadia-pinkcdiv-washington-otcwamuq-muscle-flex-otcmfli-pop-n-go-otcpopn/</link>
		<comments>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-cascadia-pinkcdiv-washington-otcwamuq-muscle-flex-otcmfli-pop-n-go-otcpopn/#comments</comments>
		<pubDate>Thu, 11 Feb 2010 07:41:16 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Bank Holding Company]]></category>
		<category><![CDATA[Cascadia]]></category>
		<category><![CDATA[CEO Danny Alex]]></category>
		<category><![CDATA[Danny Alex]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[internet development company]]></category>
		<category><![CDATA[investments inc]]></category>
		<category><![CDATA[media initiative]]></category>
		<category><![CDATA[mfli]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[mutual]]></category>
		<category><![CDATA[N Go]]></category>
		<category><![CDATA[Otc]]></category>
		<category><![CDATA[Pacific]]></category>
		<category><![CDATA[Pop]]></category>
		<category><![CDATA[small cap companies]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[Term Earnings]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington Mutual Inc]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1627</guid>
		<description><![CDATA[Below is a list of the small cap companies that have been making waves accross some of the world#8217;s most popular stock market forums on Thursday, February 11, 2010.
News Updates for: Cascadia Investments (PINK:CDIV), Washington Mutual (OTC:WAMUQ), Muscle Flex, Inc. (OTC:MFLI), and Pop N Go (OTC:POPN)

Cascadia Investments Inc.
(Public, PINK:CDIV)
Cascadia Investments, Inc. (PINKSHEETS: CDIV) today announced [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/the-most-talked-about-small-cap-stocks-on-the-net-cascadia-pinkcdiv-washington-otcwamuq-muscle-flex-otcmfli-pop-n-go-otcpopn/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Has Toyota (NYSE:TM) Found A Real Low?</title>
		<link>http://www.straightstocks.com/stock-watch/has-toyota-nysetm-found-a-real-low/</link>
		<comments>http://www.straightstocks.com/stock-watch/has-toyota-nysetm-found-a-real-low/#comments</comments>
		<pubDate>Wed, 10 Feb 2010 19:53:46 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[chief market strategist]]></category>
		<category><![CDATA[federal investigators]]></category>
		<category><![CDATA[Ford]]></category>
		<category><![CDATA[Ford Motors]]></category>
		<category><![CDATA[king toyota]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[news]]></category>
		<category><![CDATA[Nicholas Santiago;]]></category>
		<category><![CDATA[point decline]]></category>
		<category><![CDATA[recall]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[stock ford]]></category>
		<category><![CDATA[Toyota]]></category>
		<category><![CDATA[Toyota Motors;]]></category>
		<category><![CDATA[traders point]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1598</guid>
		<description><![CDATA[Toyota Motors (NYSE:TM) has been on the hot seat recently. Toyota issued a massive recall due to an accelerator problem. This recall has affected millions of vehicles and the owners of theses vehicles. Politicians and federal investigators have made statements about the recall from Toyota as the company is in the news every single day.
On [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/has-toyota-nysetm-found-a-real-low/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does Panic Equal Buying Opportunity On United States Oil Fund LP (NYSE:USO)</title>
		<link>http://www.straightstocks.com/stock-watch/does-panic-equal-buying-opportunity-on-united-states-oil-fund-lp-nyseuso/</link>
		<comments>http://www.straightstocks.com/stock-watch/does-panic-equal-buying-opportunity-on-united-states-oil-fund-lp-nyseuso/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 11:52:44 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Bounce]]></category>
		<category><![CDATA[Capitulation]]></category>
		<category><![CDATA[Day;]]></category>
		<category><![CDATA[Lows]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[probability]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[Swing]]></category>
		<category><![CDATA[technical volume]]></category>
		<category><![CDATA[term]]></category>
		<category><![CDATA[Uso]]></category>
		<category><![CDATA[Volume]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1583</guid>
		<description><![CDATA[Oil (NYSE:USO) is trading near the lows of the day following massive technical selling that was triggered at a break of $35.25.  The dump has taken the USO down to the master support region between $34.25 #8211; $33.75.  This range will have a high probability of a bounce on oil and should be watched for a [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/does-panic-equal-buying-opportunity-on-united-states-oil-fund-lp-nyseuso/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>High-Definition Firearms Training Simulators: The Future of Combat Training</title>
		<link>http://www.straightstocks.com/stock-watch/high-definition-firearms-training-simulators-the-future-of-combat-training/</link>
		<comments>http://www.straightstocks.com/stock-watch/high-definition-firearms-training-simulators-the-future-of-combat-training/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 11:49:38 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Bob Ferris]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[department]]></category>
		<category><![CDATA[Ferris Productions]]></category>
		<category><![CDATA[Fire Belt]]></category>
		<category><![CDATA[firearms training]]></category>
		<category><![CDATA[gem company]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Great Lakes]]></category>
		<category><![CDATA[Gwinnett County]]></category>
		<category><![CDATA[Keegan]]></category>
		<category><![CDATA[Long Term Investment]]></category>
		<category><![CDATA[Martin]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nashville]]></category>
		<category><![CDATA[Oregon]]></category>
		<category><![CDATA[Pink Sheet Stocks]]></category>
		<category><![CDATA[police;]]></category>
		<category><![CDATA[profitable quarters]]></category>
		<category><![CDATA[South America]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[VirTra]]></category>
		<category><![CDATA[virtra systems inc]]></category>
		<category><![CDATA[VTSI]]></category>
		<category><![CDATA[Washington]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1587</guid>
		<description><![CDATA[VirTra Systems, Inc.
(Public, OTC:VTSI)
VirTra is without a doubt one of the best performing Pink Sheet stocks around, having posted six consecutive profitable quarters and rather quickly making its way onto the seventh. With worldwide government spending on simulation and virtual training  totalling $7.9B and increasing each year, this booming market continues to post [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/high-definition-firearms-training-simulators-the-future-of-combat-training/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bullish Technical Trading Alert Issued on Endeavour International</title>
		<link>http://www.straightstocks.com/stock-watch/bullish-technical-trading-alert-issued-on-endeavour-international/</link>
		<comments>http://www.straightstocks.com/stock-watch/bullish-technical-trading-alert-issued-on-endeavour-international/#comments</comments>
		<pubDate>Fri, 05 Feb 2010 18:23:20 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[amex]]></category>
		<category><![CDATA[com]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Company Insiders]]></category>
		<category><![CDATA[corporation]]></category>
		<category><![CDATA[Couple Of Days]]></category>
		<category><![CDATA[Endeavour]]></category>
		<category><![CDATA[endeavour international corporation]]></category>
		<category><![CDATA[international]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[upcoming news]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1578</guid>
		<description><![CDATA[Endeavour International Corporation
(Public, AMEX:END)
A bullish technical trading alert has been issued by TheMarketFinancial.Com on Endeavour International Corporation after company insiders purchased in excess of $5,954,998  USD on the open market at a $0.90 price per share the last couple of days. This activity is generally perceived as a strong indicator of the company#8217;s shares rising [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bullish-technical-trading-alert-issued-on-endeavour-international/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VirTra Systems CEO Set To Provide Company Update</title>
		<link>http://www.straightstocks.com/stock-watch/virtra-systems-ceo-set-to-provide-company-update/</link>
		<comments>http://www.straightstocks.com/stock-watch/virtra-systems-ceo-set-to-provide-company-update/#comments</comments>
		<pubDate>Fri, 05 Feb 2010 07:14:53 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[class customer service]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[consecutive profitable quarter]]></category>
		<category><![CDATA[degree]]></category>
		<category><![CDATA[distinct product lines]]></category>
		<category><![CDATA[firearms training]]></category>
		<category><![CDATA[marksmanship]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mr. Ferris]]></category>
		<category><![CDATA[Pink Sheet Stocks]]></category>
		<category><![CDATA[Series;]]></category>
		<category><![CDATA[training]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[VirTra]]></category>
		<category><![CDATA[virtra systems inc]]></category>
		<category><![CDATA[World Scenarios]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1569</guid>
		<description><![CDATA[VirTra Systems, Inc.
(Public, OTC:VTSI.pk)
VirTra Systems and TheMarketFinancial.com have come to terms on collaborating and providing an update for the company to its shareholders. Along with a company profile, a questions and answers session has been confirmed and the date of release is tentative for 02/08/10. We have recently contacted Mr. Ferris expressing interest in the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/virtra-systems-ceo-set-to-provide-company-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Did you expect anything different?</title>
		<link>http://www.straightstocks.com/stock-watch/did-you-expect-anything-different/</link>
		<comments>http://www.straightstocks.com/stock-watch/did-you-expect-anything-different/#comments</comments>
		<pubDate>Thu, 04 Feb 2010 18:54:15 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[bernanke]]></category>
		<category><![CDATA[Central Banks]]></category>
		<category><![CDATA[correction]]></category>
		<category><![CDATA[Diamonds Trust]]></category>
		<category><![CDATA[Great Depression]]></category>
		<category><![CDATA[Janet Jackson]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mr. Bernanke]]></category>
		<category><![CDATA[Nicholas Santiago;]]></category>
		<category><![CDATA[Party]]></category>
		<category><![CDATA[percent]]></category>
		<category><![CDATA[Pullbacks]]></category>
		<category><![CDATA[QQQQ]]></category>
		<category><![CDATA[Rally]]></category>
		<category><![CDATA[SPDR Trust]]></category>
		<category><![CDATA[stock market history]]></category>
		<category><![CDATA[year]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1561</guid>
		<description><![CDATA[The rally from the March 2009 lows was one of the largest rallies we have ever witnessed in stock market history. While the ninth year of a decade is usually a bullish trading year there a very few people who expected an advance over fifty percent off the lows. Many traders and investors including myself [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/did-you-expect-anything-different/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Watchlist: Updates for Novo Nordisk, IntelGenx Corp, Cytomedix Inc, Par Pharmaceutical Companies</title>
		<link>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-novo-nordisk-intelgenx-corp-cytomedix-inc-par-pharmaceutical-companies/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-novo-nordisk-intelgenx-corp-cytomedix-inc-par-pharmaceutical-companies/#comments</comments>
		<pubDate>Thu, 04 Feb 2010 09:13:09 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biovail;]]></category>
		<category><![CDATA[cardiovascular safety profile]]></category>
		<category><![CDATA[Cary;]]></category>
		<category><![CDATA[Cytomedix Inc.]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[insulin release]]></category>
		<category><![CDATA[IntelGenx]]></category>
		<category><![CDATA[Liraglutide]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nda]]></category>
		<category><![CDATA[Novo Nordisk]]></category>
		<category><![CDATA[NVO]]></category>
		<category><![CDATA[thyroid tumors]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[Warner Chilcott Plc]]></category>
		<category><![CDATA[Wellbutrin Xl]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1556</guid>
		<description><![CDATA[Updates for: Novo Nordisk (NYSE:NVO), IntelGenx Corp. (OTC:IGXT), Cytomedix Inc. (AMEX:GTF), and Par Pharmaceutical Companies Inc. (NYSE:PRX)
Warner Chilcott PLC
(NYSE:NVO)

On 9/23/09, Novo Nordisk (NYSE: NVO) announced the delay until 4Q09 of formal feedback from the FDA for its pending Victoza (liraglutide is a once-daily human GLP-1 analogue) NDA seeking U.S. marketing approval for the treatment of [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-novo-nordisk-intelgenx-corp-cytomedix-inc-par-pharmaceutical-companies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VirTra Systems In The Spotlight, Technical Analysis</title>
		<link>http://www.straightstocks.com/stock-watch/virtra-systems-in-the-spotlight-technical-analysis/</link>
		<comments>http://www.straightstocks.com/stock-watch/virtra-systems-in-the-spotlight-technical-analysis/#comments</comments>
		<pubDate>Wed, 03 Feb 2010 19:20:25 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Consolidation]]></category>
		<category><![CDATA[firearms training]]></category>
		<category><![CDATA[immersive virtual reality]]></category>
		<category><![CDATA[ivr]]></category>
		<category><![CDATA[macd divergence]]></category>
		<category><![CDATA[marksmanship training]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[military firearms]]></category>
		<category><![CDATA[paradigm shift]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[TIME;]]></category>
		<category><![CDATA[training]]></category>
		<category><![CDATA[virtra systems inc]]></category>
		<category><![CDATA[VTSI]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1548</guid>
		<description><![CDATA[VirTra Systems Inc. (OTC:VTSI.pk) has been receiving a lot of praise lately as indicated by the strong bullish volume the last couple of days. Despite this, what goes up must at some point come down #8212; atleast a little bit. Today marks a break in this momentum and thus establishes it as a consolidation period, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/virtra-systems-in-the-spotlight-technical-analysis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Highly Bullish Technical Trading Alert Issued for Generex, Golden Cross Imminent</title>
		<link>http://www.straightstocks.com/stock-watch/highly-bullish-technical-trading-alert-issued-for-generex-golden-cross-imminent/</link>
		<comments>http://www.straightstocks.com/stock-watch/highly-bullish-technical-trading-alert-issued-for-generex-golden-cross-imminent/#comments</comments>
		<pubDate>Mon, 01 Feb 2010 07:07:16 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biotechnology Companies]]></category>
		<category><![CDATA[biotechnology corporation]]></category>
		<category><![CDATA[Generex]]></category>
		<category><![CDATA[GNBT]]></category>
		<category><![CDATA[Golden Cross]]></category>
		<category><![CDATA[level]]></category>
		<category><![CDATA[macd divergence]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[N.I.C.E]]></category>
		<category><![CDATA[news]]></category>
		<category><![CDATA[Price;]]></category>
		<category><![CDATA[relative strength index]]></category>
		<category><![CDATA[relative strength index rsi]]></category>
		<category><![CDATA[share level]]></category>
		<category><![CDATA[stock]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1538</guid>
		<description><![CDATA[A highly bullish technical trade alert has been issued on Generex Biotechnology Corporation (NASDAQ:GNBT) on the even of the N.I.C.E. conference news. The company was recently introduced on our website as one of the most undervalued biotechnology companies of the early 2010 year, keeping investors glued to the screen as they await any new developments. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/highly-bullish-technical-trading-alert-issued-for-generex-golden-cross-imminent/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Provision Confirms Further Contract Talks, New Business Strategies</title>
		<link>http://www.straightstocks.com/stock-watch/provision-confirms-further-contract-talks-new-business-strategies/</link>
		<comments>http://www.straightstocks.com/stock-watch/provision-confirms-further-contract-talks-new-business-strategies/#comments</comments>
		<pubDate>Sun, 31 Jan 2010 00:53:21 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Cnn]]></category>
		<category><![CDATA[dorky glasses]]></category>
		<category><![CDATA[fortune 1000 companies]]></category>
		<category><![CDATA[futuristic nature]]></category>
		<category><![CDATA[interactive technologies inc]]></category>
		<category><![CDATA[market channels]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[persuasive manner]]></category>
		<category><![CDATA[technological capabilities]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1533</guid>
		<description><![CDATA[Provision Holding Inc
(Public, OTC:PVHO)
Last Friday, TheMarketFinancial was given the opportunity to conduct a follow up conference call with Provision Holding CEO, Curt Thornton. The conference call was headlined by new company events, news, contracts, confirmation of rumours, and most importantly, a new technological advancement which will be explred through their new found deal with Phantasmic. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/provision-confirms-further-contract-talks-new-business-strategies/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Provision Holding Conference Call to be Released on 30/1/10</title>
		<link>http://www.straightstocks.com/stock-watch/provision-holding-conference-call-to-be-released-on-30110/</link>
		<comments>http://www.straightstocks.com/stock-watch/provision-holding-conference-call-to-be-released-on-30110/#comments</comments>
		<pubDate>Sat, 30 Jan 2010 00:24:07 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[consumer attention]]></category>
		<category><![CDATA[contract states]]></category>
		<category><![CDATA[current assets]]></category>
		<category><![CDATA[Emerging Company]]></category>
		<category><![CDATA[Gaming Market]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[product merchandising]]></category>
		<category><![CDATA[video displays]]></category>
		<category><![CDATA[vlaicu]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1525</guid>
		<description><![CDATA[Provision Holding Inc.
(Public, OTC:PVHO)
We are happy to announce that TheMarketFinancial.com was the first source on the Internet to establish a conference call with Provision Holding Inc. (OTC:PVHO) regarding their recent contract. Below is a summary of the interview which will be made available for you to listen in on as of 30/1/10, ETA by 6pm [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/provision-holding-conference-call-to-be-released-on-30110/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unusual Volume Movers for 01/29/10 – Klegg (OTC:KLGG), Biomoda (OTC:BMOD)</title>
		<link>http://www.straightstocks.com/stock-watch/unusual-volume-movers-for-012910-%e2%80%93-klegg-otcklgg-biomoda-otcbmod/</link>
		<comments>http://www.straightstocks.com/stock-watch/unusual-volume-movers-for-012910-%e2%80%93-klegg-otcklgg-biomoda-otcbmod/#comments</comments>
		<pubDate>Fri, 29 Jan 2010 20:29:26 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Albuquerque]]></category>
		<category><![CDATA[albuquerque new mexico]]></category>
		<category><![CDATA[baystreet]]></category>
		<category><![CDATA[Biomoda]]></category>
		<category><![CDATA[Biomoda Inc.]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer death]]></category>
		<category><![CDATA[cancer diagnostics]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[lung]]></category>
		<category><![CDATA[lung cancer patients]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[New Mexico]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[stock ticker symbol]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[wall street investors]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1520</guid>
		<description><![CDATA[Below is a list of the companies that made news, or had unusually high volume on Friday, January 29, 2010.

Klegg Electronics Inc.
(Public, OTC:KLGG)
We have found no news regarding the massive volume seen today. Many speculators are leaning towards massive promotions and artificial pumps in the stock price. We advice potential current and new investors to [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/unusual-volume-movers-for-012910-%e2%80%93-klegg-otcklgg-biomoda-otcbmod/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conference Call Announced on 29/1/10 for Provision Regarding Important Company Updates</title>
		<link>http://www.straightstocks.com/stock-watch/conference-call-announced-on-29110-for-provision-regarding-important-company-updates/</link>
		<comments>http://www.straightstocks.com/stock-watch/conference-call-announced-on-29110-for-provision-regarding-important-company-updates/#comments</comments>
		<pubDate>Thu, 28 Jan 2010 09:24:27 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[2d displays]]></category>
		<category><![CDATA[3d market]]></category>
		<category><![CDATA[important company]]></category>
		<category><![CDATA[insight media]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[new decade]]></category>
		<category><![CDATA[stereoscopic 3d]]></category>
		<category><![CDATA[Target Market]]></category>
		<category><![CDATA[technology enthusiasts]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1506</guid>
		<description><![CDATA[With the recent success of the movie Avatar, and the way it sank Titanic on route to becoming the world#8217;s #1 earning box office movie of all time, seems everyone is talking about 3-D display these days. There is no doubt 2010 is shaping up to be the year of 3-D. Consumers and technology enthusiasts alike [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/conference-call-announced-on-29110-for-provision-regarding-important-company-updates/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>High Volume Movers for 01/27/10 – Repros (NASDAQ:RPRX), Provision (OTC:PVHO), La Jolla (NASDAQ:LJPC), Bonanza Oil (OTC:BGOI)</title>
		<link>http://www.straightstocks.com/stock-watch/high-volume-movers-for-012710-%e2%80%93-repros-nasdaqrprx-provision-otcpvho-la-jolla-nasdaqljpc-bonanza-oil-otcbgoi/</link>
		<comments>http://www.straightstocks.com/stock-watch/high-volume-movers-for-012710-%e2%80%93-repros-nasdaqrprx-provision-otcpvho-la-jolla-nasdaqljpc-bonanza-oil-otcbgoi/#comments</comments>
		<pubDate>Wed, 27 Jan 2010 19:27:12 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[CEO Curt Thornton]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Curt Thornton]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[holovision]]></category>
		<category><![CDATA[hypothalamic pituitary axis]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[interactive technologies inc]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nasdaq]]></category>
		<category><![CDATA[NasdaqCM]]></category>
		<category><![CDATA[Provision]]></category>
		<category><![CDATA[Repros]]></category>
		<category><![CDATA[rprx]]></category>
		<category><![CDATA[secondary hypogonadism]]></category>
		<category><![CDATA[Therapeutics Inc]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Wall Street Journal]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1494</guid>
		<description><![CDATA[Below is a list of the companies that made news, or had unusually high volume on Wednesday, January 27, 2010.

Repros Therapeutics Inc.
(Public, NASDAQ:RPRX)
Repros Therapeutics Inc. (NasdaqCM:RPRX) today announced that the Company and its consultants participated in a teleconference with the Division of Reproductive and Urologic Products of the FDA on January 25, 2010. The primary [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/high-volume-movers-for-012710-%e2%80%93-repros-nasdaqrprx-provision-otcpvho-la-jolla-nasdaqljpc-bonanza-oil-otcbgoi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Electronic Cigarette Wholesaler Empowered After U.S. Judge Decision Against FDA</title>
		<link>http://www.straightstocks.com/stock-watch/electronic-cigarette-wholesaler-empowered-after-u-s-judge-decision-against-fda/</link>
		<comments>http://www.straightstocks.com/stock-watch/electronic-cigarette-wholesaler-empowered-after-u-s-judge-decision-against-fda/#comments</comments>
		<pubDate>Mon, 25 Jan 2010 09:50:05 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[aggressive efforts]]></category>
		<category><![CDATA[Brad Rodu]]></category>
		<category><![CDATA[Brand Cigarette]]></category>
		<category><![CDATA[Christchurch;]]></category>
		<category><![CDATA[cigarette]]></category>
		<category><![CDATA[cigarette industry]]></category>
		<category><![CDATA[company article]]></category>
		<category><![CDATA[Dr. Joel Nitzkin]]></category>
		<category><![CDATA[Dr. Michael Siegel]]></category>
		<category><![CDATA[Dr. Rodu]]></category>
		<category><![CDATA[Electronic]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[Joel L. Nitzkin]]></category>
		<category><![CDATA[landmark victory]]></category>
		<category><![CDATA[M. Safety]]></category>
		<category><![CDATA[Michael Siegel]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[NAT NAB Total]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[question]]></category>
		<category><![CDATA[richard leon]]></category>
		<category><![CDATA[technical standpoint]]></category>
		<category><![CDATA[Than]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[Verify Claims]]></category>
		<category><![CDATA[vlaicu]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1417</guid>
		<description><![CDATA[Mobile Media Unlimited Holdings Inc.
(OTC:MMUH)
On the eve of one of the most important and influential decisions to hit the United States of America within the last decade, electronic cigarettes now have a chance to leap forward and compete with the tobacco empire. This, in itself represents a tremendous opportunity for investors looking to make big [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/electronic-cigarette-wholesaler-empowered-after-u-s-judge-decision-against-fda/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Insight Into Goldman Sachs Earnings: What Main Street Should Be Worried About</title>
		<link>http://www.straightstocks.com/stock-watch/insight-into-goldman-sachs-earnings-what-main-street-should-be-worried-about/</link>
		<comments>http://www.straightstocks.com/stock-watch/insight-into-goldman-sachs-earnings-what-main-street-should-be-worried-about/#comments</comments>
		<pubDate>Thu, 21 Jan 2010 15:13:49 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[computer trading]]></category>
		<category><![CDATA[Earnings Per Share]]></category>
		<category><![CDATA[Gareth Soloway;]]></category>
		<category><![CDATA[Goldman]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[goldman sachs grp]]></category>
		<category><![CDATA[JP Morgan Chase]]></category>
		<category><![CDATA[Main Street]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Net Profits]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[nyse jpm]]></category>
		<category><![CDATA[President Obama]]></category>
		<category><![CDATA[revenue]]></category>
		<category><![CDATA[Sachs]]></category>
		<category><![CDATA[share]]></category>
		<category><![CDATA[trading]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Wells]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1379</guid>
		<description><![CDATA[Goldman Sachs Grp. (NYSE:GS) reported net profits of $8.20 per share on revenue of $9.62 billion.  This blew away the earnings per share number which was expected at $5.20, however, missed the revenue number slightly which had been expected at $9.65 billion. When analyzing these numbers, this is just the start.
The key with Goldman [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/insight-into-goldman-sachs-earnings-what-main-street-should-be-worried-about/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Watchlist: Updates for Warner Chilcott, AstraZeneca, Dainippon Sumitomo, Nanosphere</title>
		<link>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-warner-chilcott-astrazeneca-dainippon-sumitomo-nanosphere/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-warner-chilcott-astrazeneca-dainippon-sumitomo-nanosphere/#comments</comments>
		<pubDate>Thu, 21 Jan 2010 09:11:18 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[application]]></category>
		<category><![CDATA[Astrazeneca Plc]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cell lung cancer]]></category>
		<category><![CDATA[dainippon sumitomo]]></category>
		<category><![CDATA[Date]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[medullary thyroid cancer]]></category>
		<category><![CDATA[mg monotherapy]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nanosphere Inc.;]]></category>
		<category><![CDATA[nasdaq]]></category>
		<category><![CDATA[Nda]]></category>
		<category><![CDATA[NSPH]]></category>
		<category><![CDATA[partial onset seizures]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[Warner Chilcott]]></category>
		<category><![CDATA[Warner Chilcott Plc]]></category>
		<category><![CDATA[Zephyr;]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1373</guid>
		<description><![CDATA[Updates for: Warner Chilcott PLC (NASDAQ:WCRX), AstraZeneca PLC (NYSE:AZN), Dainippon Sumitomo Pharma (PINK:DNPUF), and Nanosphere, Inc. (NASDAQ:NSPH)
Warner Chilcott PLC
(NASDAQ:WCRX)

On 5/27/09, Warner Chilcott (NASDAQ: WCRX) announced that the FDA has filed for standard review (10 months) the new drug application (NDA) for WC 3016, a low dose oral contraceptive. The NDA for WC 3016 was submitted [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-watchlist-updates-for-warner-chilcott-astrazeneca-dainippon-sumitomo-nanosphere/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech FDA Mailbag: Updates for Bovie Medical, Acorda Therapeutics</title>
		<link>http://www.straightstocks.com/stock-watch/biotech-fda-mailbag-updates-for-bovie-medical-acorda-therapeutics/</link>
		<comments>http://www.straightstocks.com/stock-watch/biotech-fda-mailbag-updates-for-bovie-medical-acorda-therapeutics/#comments</comments>
		<pubDate>Wed, 20 Jan 2010 21:43:21 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Acorda Therapeutics Inc.;]]></category>
		<category><![CDATA[Acorda;]]></category>
		<category><![CDATA[advisory panel meetings]]></category>
		<category><![CDATA[bvx]]></category>
		<category><![CDATA[Date]]></category>
		<category><![CDATA[device submissions]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[fda response]]></category>
		<category><![CDATA[general surgery]]></category>
		<category><![CDATA[HAWTHORNE;]]></category>
		<category><![CDATA[M.D.]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Micro Cap Companies]]></category>
		<category><![CDATA[monopolar]]></category>
		<category><![CDATA[N.Y]]></category>
		<category><![CDATA[Nda]]></category>
		<category><![CDATA[PDUFA]]></category>
		<category><![CDATA[Review]]></category>
		<category><![CDATA[Ron Cohen;]]></category>
		<category><![CDATA[sbla]]></category>
		<category><![CDATA[U.S. Food]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1360</guid>
		<description><![CDATA[Updates for: Bovie Medical Corporation (AMEX:BVX), and Acorda Therapeutics (NASDAQ:ACOR)
The following is a list of companies which includes the company name, ticker symbol, decision date, and the lastest updated description and notes. Each entry includes a summary of the pending regulatory or clinical trial catalyst event and other relevant information such as FDA Advisory Panel [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/biotech-fda-mailbag-updates-for-bovie-medical-acorda-therapeutics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Priced for Perfection: When Good Stocks Turn Bad</title>
		<link>http://www.straightstocks.com/stock-watch/priced-for-perfection-when-good-stocks-turn-bad/</link>
		<comments>http://www.straightstocks.com/stock-watch/priced-for-perfection-when-good-stocks-turn-bad/#comments</comments>
		<pubDate>Wed, 20 Jan 2010 20:56:10 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Chief Market]]></category>
		<category><![CDATA[corporate earnings]]></category>
		<category><![CDATA[Current Stock Price]]></category>
		<category><![CDATA[earnings announcement]]></category>
		<category><![CDATA[Earnings Season]]></category>
		<category><![CDATA[event]]></category>
		<category><![CDATA[International Business Machines]]></category>
		<category><![CDATA[J.P. Morgan Chase]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[market strategists]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nicholas Santiago;]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[nyse jpm]]></category>
		<category><![CDATA[release]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[Team]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1353</guid>
		<description><![CDATA[As corporate earnings season is fully underway many of the shining star stocks have sold off after their earnings release. The first major stock to report two weeks ago was Alcoa (NYSE:AA). The stock had an amazing move higher trading at a high print of 17.60 prior to it#8217;s earnings release. Once the earnings were [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/priced-for-perfection-when-good-stocks-turn-bad/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Make or Break,Technicals and Earnings on Tap Showing this Week Means Everything</title>
		<link>http://www.straightstocks.com/stock-watch/make-or-breaktechnicals-and-earnings-on-tap-showing-this-week-means-everything/</link>
		<comments>http://www.straightstocks.com/stock-watch/make-or-breaktechnicals-and-earnings-on-tap-showing-this-week-means-everything/#comments</comments>
		<pubDate>Wed, 20 Jan 2010 08:54:41 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[52 week highs]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[earnings whisper numbers]]></category>
		<category><![CDATA[Gareth Soloway;]]></category>
		<category><![CDATA[general electric co]]></category>
		<category><![CDATA[goldman sachs grp]]></category>
		<category><![CDATA[Ibm]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[intl business mach]]></category>
		<category><![CDATA[JP Morgan Chase]]></category>
		<category><![CDATA[JP Morgan Chase & Co.]]></category>
		<category><![CDATA[Main Street]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nyse]]></category>
		<category><![CDATA[nyse jpm]]></category>
		<category><![CDATA[The Street]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Watch]]></category>
		<category><![CDATA[week]]></category>
		<category><![CDATA[Wells]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1346</guid>
		<description><![CDATA[After earnings announcements from Alcoa Inc. (NYSE:AA), Intel Corporation (NASDAQ:INTC) and JP Morgan Chase Co. (NYSE:JPM) did not live up to expectations and their stocks fell, the market is beginning to get a little nervous.  We have seen the market have some recent sharp declines on these earnings, each following day it has bounced [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/make-or-breaktechnicals-and-earnings-on-tap-showing-this-week-means-everything/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Generex Moves Towards Treatments for Diabetes, Cancer (NASDAQ:GNBT)</title>
		<link>http://www.straightstocks.com/stock-watch/generex-moves-towards-treatments-for-diabetes-cancer-nasdaqgnbt/</link>
		<comments>http://www.straightstocks.com/stock-watch/generex-moves-towards-treatments-for-diabetes-cancer-nasdaqgnbt/#comments</comments>
		<pubDate>Tue, 19 Jan 2010 15:11:11 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[biotechnology corporation]]></category>
		<category><![CDATA[corporation]]></category>
		<category><![CDATA[Generex]]></category>
		<category><![CDATA[GNBT]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nasdaq]]></category>
		<category><![CDATA[public]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1342</guid>
		<description><![CDATA[Generex Biotechnology Corporation
(Public, NASDAQ:GNBT)



                                
				  
                  [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/generex-moves-towards-treatments-for-diabetes-cancer-nasdaqgnbt/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ranking the Top 10 Healthcare Stocks by Upside Potential</title>
		<link>http://www.straightstocks.com/stock-watch/ranking-the-top-10-healthcare-stocks-by-upside-potential/</link>
		<comments>http://www.straightstocks.com/stock-watch/ranking-the-top-10-healthcare-stocks-by-upside-potential/#comments</comments>
		<pubDate>Tue, 19 Jan 2010 06:43:26 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[biotechnology corporation]]></category>
		<category><![CDATA[cbrx]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[GNBT]]></category>
		<category><![CDATA[Healthcare Stocks]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[la jolla pharmaceutical]]></category>
		<category><![CDATA[La Jolla Pharmaceutical Company;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[nasdaq]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Price;]]></category>
		<category><![CDATA[Target Price]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Wall Street Analysts]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1324</guid>
		<description><![CDATA[Below is a ranking of the top 10 U.S.-listed healthcare stocks based on upside potential, calculated as the difference between current price and Wall Street analysts#8217; average target price.

Ranking  #124;  Company (Ticker)  #124;  Potential Upside
1 Anesiva, Inc. (NASDAQ:ANSV) 10276.1%
2 La Jolla Pharmaceutical Company (NASDAQ:LJPC) 3645.5%
3 Generex Biotechnology Corporation (NASDAQ:GNBT) 1053.6%
4 Hollis-Eden Pharmaceuticals [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/ranking-the-top-10-healthcare-stocks-by-upside-potential/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unusual Market Movers for 01/15/10 – Spansion (OTC:SPSNQ), Nanogen (OTC:NGEN), Imaging3 (OTC:IMGG), Nutra Pharma (OTC:NPHC), Quasar Aerospace (PINK:QASP), Sinobiopharma (OTC:SNBP)</title>
		<link>http://www.straightstocks.com/stock-watch/unusual-market-movers-for-011510-%e2%80%93-spansion-otcspsnq-nanogen-otcngen-imaging3-otcimgg-nutra-pharma-otcnphc-quasar-aerospace-pinkqasp-sinobiopharma-otcsnbp/</link>
		<comments>http://www.straightstocks.com/stock-watch/unusual-market-movers-for-011510-%e2%80%93-spansion-otcspsnq-nanogen-otcngen-imaging3-otcimgg-nutra-pharma-otcnphc-quasar-aerospace-pinkqasp-sinobiopharma-otcsnbp/#comments</comments>
		<pubDate>Fri, 15 Jan 2010 19:50:09 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[CEO Dean Janes]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[consecutive profitable quarter]]></category>
		<category><![CDATA[Dean Bradley]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[fiscal year ended december]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Haiti]]></category>
		<category><![CDATA[imgg]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[J Deitsch]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mr. Janes]]></category>
		<category><![CDATA[Nanogen]]></category>
		<category><![CDATA[Nanogen Inc.;]]></category>
		<category><![CDATA[Nutra Pharma Corp.;]]></category>
		<category><![CDATA[Orlando]]></category>
		<category><![CDATA[Otc]]></category>
		<category><![CDATA[Pacific]]></category>
		<category><![CDATA[pacific standard time]]></category>
		<category><![CDATA[polymerase chain reaction]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Quarter;]]></category>
		<category><![CDATA[Spansion Inc.;]]></category>
		<category><![CDATA[Teva]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[U.S. GAAP]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[US]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1248</guid>
		<description><![CDATA[Below is a list of the companies that made news, or had unusually high volume on Friday, January 15, 2010.

Spansion Inc.
(Public, OTC:SPSNQ)
Spansion Inc. today announced operating results for its fourth quarter and fiscal year ended December 27, 2009. Spansion reported fourth quarter of 2009 net sales of $307.1 million and its second consecutive profitable quarter [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/unusual-market-movers-for-011510-%e2%80%93-spansion-otcspsnq-nanogen-otcngen-imaging3-otcimgg-nutra-pharma-otcnphc-quasar-aerospace-pinkqasp-sinobiopharma-otcsnbp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bullish Breakout Technical Alert (PINK:BZCN.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/bullish-breakout-technical-alert-pinkbzcn-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/bullish-breakout-technical-alert-pinkbzcn-pk/#comments</comments>
		<pubDate>Thu, 17 Dec 2009 08:08:10 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[analysis experts]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[BizAuctions]]></category>
		<category><![CDATA[BizAuctions Inc.]]></category>
		<category><![CDATA[brand name clothes]]></category>
		<category><![CDATA[BZCN]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Colorado]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Day;]]></category>
		<category><![CDATA[Ebay]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[inventory overstock]]></category>
		<category><![CDATA[liquidation services]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[retail        owners]]></category>
		<category><![CDATA[stock]]></category>
		<category><![CDATA[Technical Perspective]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=1008</guid>
		<description><![CDATA[BizAuctions Inc.
(Public, PINK:BZCN.PK)
TheMarketFinancial has initiated an independent bullish technical trading alert for 12/17/09 on BizAuctions Inc. (PINK:BZCN.PK). Shares of the company finished the day at $0.0016, down 11.11% from the opening bell. The stock reached an intraday high of $0.0020 which seemed to be a major resistance, thus causing it to fall near the $0.0016 [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bullish-breakout-technical-alert-pinkbzcn-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conference Call: Provision Aims to Establish 3D Digital Out of Home Advertising</title>
		<link>http://www.straightstocks.com/stock-watch/conference-call-provision-aims-to-establish-3d-digital-out-of-home-advertising/</link>
		<comments>http://www.straightstocks.com/stock-watch/conference-call-provision-aims-to-establish-3d-digital-out-of-home-advertising/#comments</comments>
		<pubDate>Tue, 15 Dec 2009 15:41:23 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Display]]></category>
		<category><![CDATA[distribution campaigns]]></category>
		<category><![CDATA[Due Diligence]]></category>
		<category><![CDATA[fortune 1000 companies]]></category>
		<category><![CDATA[futuristic nature]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[Initial Line]]></category>
		<category><![CDATA[Interactive]]></category>
		<category><![CDATA[interactive technologies inc]]></category>
		<category><![CDATA[interview]]></category>
		<category><![CDATA[market channels]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mr. Curt Thornton]]></category>
		<category><![CDATA[persuasive manner]]></category>
		<category><![CDATA[Provision]]></category>

		<guid isPermaLink="false">http://www.themarketfinancial.com/?p=925</guid>
		<description><![CDATA[Provision Interactive Technologies Inc. 
  (Public, OTC:PVHO.OB)
As of 12/11/09, TheMarketFinancial.com conducted a scheduled conference call interview with President and CEO of Provision Interactive Technologies Inc., Mr. Curt Thornton. The basis of the interview was to provide an executive summary, along with the respective business strategy, while touching on advertising, marketing, and distribution campaigns. The [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/conference-call-provision-aims-to-establish-3d-digital-out-of-home-advertising/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://www.themarketfinancial.com/wp-content/themes/blognews/conferences/PVHOCCFINAL.mp3" length="65048700" type="audio/mpeg" />
		</item>
		<item>
		<title>Provision Interactive Set to Revolutionize the Billion Dollar Advertising Market (OTC:PVHO.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/provision-interactive-set-to-revolutionize-the-billion-dollar-advertising-market-otcpvho-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/provision-interactive-set-to-revolutionize-the-billion-dollar-advertising-market-otcpvho-ob/#comments</comments>
		<pubDate>Wed, 02 Dec 2009 22:30:25 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Apple CEO]]></category>
		<category><![CDATA[C Series]]></category>
		<category><![CDATA[competitor analysis]]></category>
		<category><![CDATA[Curt Thornton]]></category>
		<category><![CDATA[DEO]]></category>
		<category><![CDATA[Display]]></category>
		<category><![CDATA[Distance]]></category>
		<category><![CDATA[Gil Amelio;]]></category>
		<category><![CDATA[Holo]]></category>
		<category><![CDATA[home lifestyles]]></category>
		<category><![CDATA[image]]></category>
		<category><![CDATA[indian rock art]]></category>
		<category><![CDATA[interactive technologies inc]]></category>
		<category><![CDATA[investments inc]]></category>
		<category><![CDATA[Johnson]]></category>
		<category><![CDATA[Kimberly-Clark]]></category>
		<category><![CDATA[Lyle Bunn]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Pacific]]></category>
		<category><![CDATA[Provision]]></category>
		<category><![CDATA[Q Launching]]></category>
		<category><![CDATA[revenue models]]></category>
		<category><![CDATA[revolutionary innovation]]></category>
		<category><![CDATA[Southern California]]></category>
		<category><![CDATA[T Director]]></category>
		<category><![CDATA[T Series]]></category>
		<category><![CDATA[wall paintings]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=832</guid>
		<description><![CDATA[Provision Interactive Technologies Inc. 
  (Public, OTC:PVHO.OB)
MiV Investments Inc. has initiated an independent research report on Provision Holding Inc. Starting with the traditional wall paintings traced back from Indian rock art dating back to 4000 BC, out-of-home advertisements and billboards have dominated the main stream media, thus affecting the public#8217;s opinions and buying habits [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/provision-interactive-set-to-revolutionize-the-billion-dollar-advertising-market-otcpvho-ob/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Technical Breakout Alert Issued for CytRx (NASDAQ:CYTR)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 12:35:02 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Acute Promyelocytic Leukemia]]></category>
		<category><![CDATA[acute promyelocytic leukemia apl]]></category>
		<category><![CDATA[advanced gastric cancer]]></category>
		<category><![CDATA[APL]]></category>
		<category><![CDATA[cancer indications]]></category>
		<category><![CDATA[CEO Steven A]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[CytRx Corporation]]></category>
		<category><![CDATA[drug development pipeline]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[molecular chaperone]]></category>
		<category><![CDATA[North American]]></category>
		<category><![CDATA[Response;]]></category>
		<category><![CDATA[stomach cancer;]]></category>
		<category><![CDATA[Tamibarotene]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[trial]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[U.S.  CytRx]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=827</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.14 per share, up 20.18% from the opening bell on heavy buying pressure. As of 11/18/09, the biopharmaceutical company announced plans to initiate an open-label, multinational Phase 2 clinical [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Trading Alert for Echo Therapeutics (OTC:ECTE.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-trading-alert-for-echo-therapeutics-otcecte-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-trading-alert-for-echo-therapeutics-otcecte-ob/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 13:11:14 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Ada]]></category>
		<category><![CDATA[blood]]></category>
		<category><![CDATA[blood glucose levels]]></category>
		<category><![CDATA[Boston]]></category>
		<category><![CDATA[continuous glucose monitoring system]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[diabetes care;]]></category>
		<category><![CDATA[Echo Therapeutics]]></category>
		<category><![CDATA[Franklin]]></category>
		<category><![CDATA[glucose]]></category>
		<category><![CDATA[glucose monitoring system]]></category>
		<category><![CDATA[health care dollars]]></category>
		<category><![CDATA[hospital]]></category>
		<category><![CDATA[insulin]]></category>
		<category><![CDATA[market segment]]></category>
		<category><![CDATA[Mass.]]></category>
		<category><![CDATA[medical expenditures]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[national productivity]]></category>
		<category><![CDATA[Type;]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=821</guid>
		<description><![CDATA[MivInvestments Inc. has initiated an independent bullish technical trading alert for 11/20/09 on Echo Therapeutics, Inc. (OTC:ECTE.OB). Shares of the company finished the day at $1.35, up 8.15% from the opening bell on heavy buying pressure. The excitement was due to the  announcement on positive results of a clinical study testing symphony(TM) tCGM System [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-trading-alert-for-echo-therapeutics-otcecte-ob/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Power3 Investors Looking Forward to Upcoming Expo (OTC:PWRM.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/power3-investors-looking-forward-to-upcoming-expo-otcpwrm-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/power3-investors-looking-forward-to-upcoming-expo-otcpwrm-ob/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 06:46:31 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[bone marrow aspirates]]></category>
		<category><![CDATA[breast cancer research]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chief Scientific]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[clinical validation]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[Dr. Ira Goldknopf]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[life]]></category>
		<category><![CDATA[Lou Gehrig]]></category>
		<category><![CDATA[M. About]]></category>
		<category><![CDATA[medical products inc]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Power]]></category>
		<category><![CDATA[Power3 Medical Products]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[stage breast cancer]]></category>
		<category><![CDATA[treatment of breast cancer]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=814</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/18/09 on Power3 Medical Products, Inc. (OTC:PWRM.OB). Shares of the company finished the day at $0.129, up 69.74% from the opening bell on heavy buying pressure. The spark which ignited the rise in share price is being speculated as being attributed due to [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/power3-investors-looking-forward-to-upcoming-expo-otcpwrm-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bullish Technical Breakout Alert (OTC:SNBP.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsnbp-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsnbp-ob/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 11:39:38 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[common diseases]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Down Trend]]></category>
		<category><![CDATA[Dr. Lequn]]></category>
		<category><![CDATA[generic-drugs]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[Healthcare Reform]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[investments inc]]></category>
		<category><![CDATA[Jiangsu;]]></category>
		<category><![CDATA[Lee Huang]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[miv]]></category>
		<category><![CDATA[plan]]></category>
		<category><![CDATA[record volume]]></category>
		<category><![CDATA[Sinobiopharma]]></category>
		<category><![CDATA[Universal Healthcare]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[year]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=808</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/17/09 on Sinobiopharma, Inc. (OTC:SNBP.OB). Shares of the company finished the day at $0.25, up 38.89% from the opening bell on heavy buying pressure. The turning point in the share price which had been experiencing a down trend for well over a year, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsnbp-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bullish Technical Breakout Alert (OTC:SNGX.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsngx-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsngx-ob/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 07:50:18 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[acute gvhd]]></category>
		<category><![CDATA[beclomethasone dipropionate]]></category>
		<category><![CDATA[bioterrorism agents]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Don]]></category>
		<category><![CDATA[DOR BioPharma Inc.]]></category>
		<category><![CDATA[gastrointestinal diseases]]></category>
		<category><![CDATA[graft versus host]]></category>
		<category><![CDATA[graft-versus-host disease]]></category>
		<category><![CDATA[GvHD;]]></category>
		<category><![CDATA[hematopoietic cell transplantation]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[orBec]]></category>
		<category><![CDATA[phase ;]]></category>
		<category><![CDATA[Rodman]]></category>
		<category><![CDATA[Soligenix]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=798</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/11/09 on Soligenix, Inc. (OTC:SNGX.OB). Shares of the company finished the day at $0.220, up 15.79% from the opening bell on heavy buying pressure. The turning point in the price resulted from two heavy orders of 778,980 at $0.175, and 790,000 at $0.18, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsngx-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bullish Technical Breakout Alerts (NASDAQ:NCOC), (OTC:BIEL.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alerts-nasdaqncoc-otcbiel-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alerts-nasdaqncoc-otcbiel-pk/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 02:44:13 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[BioElectronics]]></category>
		<category><![CDATA[BioElectronics Corp.]]></category>
		<category><![CDATA[bofa]]></category>
		<category><![CDATA[coal]]></category>
		<category><![CDATA[coal exporters]]></category>
		<category><![CDATA[Coal Prices]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Corp]]></category>
		<category><![CDATA[East Tennessee]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[national coal]]></category>
		<category><![CDATA[National;]]></category>
		<category><![CDATA[Norfolk]]></category>
		<category><![CDATA[North Alabama]]></category>
		<category><![CDATA[Rand]]></category>
		<category><![CDATA[saudi arabian riyal]]></category>
		<category><![CDATA[South African Rand]]></category>
		<category><![CDATA[Southeast Kentucky]]></category>
		<category><![CDATA[Southern Appalachian]]></category>
		<category><![CDATA[steam coal]]></category>
		<category><![CDATA[Straight Creek]]></category>
		<category><![CDATA[Tennessee]]></category>
		<category><![CDATA[UAE]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=788</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/10/09 on National Coal Corp. (NASDAQ:NCOC) and BioElectronics Corp. (OTC:BIEL.PK). BioElectronics Corp. gained tremendous buying pressure leading into market close, and National Coal Corp. saw its shares rise 7.62% within after hours trading on high volume.


About National Coal Corp.
National Coal Corp. is engaged [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alerts-nasdaqncoc-otcbiel-pk/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Burning the Calories with CardioCor (PINK:CDOI.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/burning-the-calories-with-cardiocor-pinkcdoi-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/burning-the-calories-with-cardiocor-pinkcdoi-pk/#comments</comments>
		<pubDate>Wed, 04 Nov 2009 11:46:53 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[aggressive growth plan]]></category>
		<category><![CDATA[AL]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Beauty]]></category>
		<category><![CDATA[Birmingham]]></category>
		<category><![CDATA[Cardio]]></category>
		<category><![CDATA[Carol]]></category>
		<category><![CDATA[CAROL ANGLIN]]></category>
		<category><![CDATA[CEO Wayne]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Cor]]></category>
		<category><![CDATA[East Coast]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Good Morning America;]]></category>
		<category><![CDATA[Inc]]></category>
		<category><![CDATA[infrared technologies inc]]></category>
		<category><![CDATA[investments inc]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[M.B.A.]]></category>
		<category><![CDATA[Market Segments]]></category>
		<category><![CDATA[medical markets]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[obesity levels]]></category>
		<category><![CDATA[part]]></category>
		<category><![CDATA[prevalence of obesity]]></category>
		<category><![CDATA[Reinhardt]]></category>
		<category><![CDATA[Scott]]></category>
		<category><![CDATA[T.N.D. Elle]]></category>
		<category><![CDATA[U.S]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[Wayne ;]]></category>
		<category><![CDATA[Wayne Bailey]]></category>
		<category><![CDATA[Wayne K. Bailey]]></category>
		<category><![CDATA[West Coast]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=777</guid>
		<description><![CDATA[CARDIO INFRARED TECHNOLOGIES INC.

(Public, PINK:CDOI.PK)

http://cardio-cor.com/

MiV Investments Inc. has initiated independent research coverage on Cardio Infrared  Techs Inc, a company that looks to profit as America#8217;s negative habbits and lifestyles begin to catch up to them. Their phase II Clinical trials are set to be completed by 4Q09, and  it couldn#8217;t come at a [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/burning-the-calories-with-cardiocor-pinkcdoi-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Awaiting IND Targetting a Twenty-Eight Billion Dollar Market (OTC:ACTC.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/awaiting-ind-targetting-a-twenty-eight-billion-dollar-market-otcactc-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/awaiting-ind-targetting-a-twenty-eight-billion-dollar-market-otcactc-ob/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 13:15:48 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=768</guid>
		<description><![CDATA[Advanced Cell Technology, Inc.
(Public, OTC:ACTC.OB)
MiV Investments Inc. has initiated independent research coverage on Advanced Cell Technology Inc. (OTC:ACTC.OB), which is anticipating  a filing of an investigational new drug (IND) application which takes on a 28B Age-related macular degeneration (AMD)  market, with over 30 million people affected by the disease. The company expects to [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/awaiting-ind-targetting-a-twenty-eight-billion-dollar-market-otcactc-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Empowering Alternative Renewable Energy from Disposable Waste (PINK:WTWO.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/empowering-alternative-renewable-energy-from-disposable-waste-pinkwtwo-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/empowering-alternative-renewable-energy-from-disposable-waste-pinkwtwo-pk/#comments</comments>
		<pubDate>Tue, 27 Oct 2009 12:04:31 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=756</guid>
		<description><![CDATA[W2 ENERGY, Inc.

(PINK:WTWO.PK)
MiV Investments initiates an independent company profile on W2 Energy, Inc. (PINK:WTWO.PK), which looks to breakthrough within a $23B bio-fuel industry, as a successful alternative renewable energy company amongst worldwide rising oil and energy prices. since the dawn of technological advancements, the world has relied on the burning of fossil fuels in order [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/empowering-alternative-renewable-energy-from-disposable-waste-pinkwtwo-pk/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>BioCurex Poised for Positive Future Based on Results (OTC:BOCX)</title>
		<link>http://www.straightstocks.com/stock-watch/biocurex-poised-for-positive-future-based-on-results-otcbocx/</link>
		<comments>http://www.straightstocks.com/stock-watch/biocurex-poised-for-positive-future-based-on-results-otcbocx/#comments</comments>
		<pubDate>Mon, 26 Oct 2009 14:55:22 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=742</guid>
		<description><![CDATA[BioCurex Inc
(Public, OTC:BOCX)
http://www.biocurex.com/
BioCurex, Inc. (“BioCurex” or “the Company”) is a biotechnology company developing products for cancerdiagnosis, imaging, and therapy that target a global oncology market forecast to reach over $50 billion by 2009. The Company uses a novel, patented technology based on the RECAF™ cancer marker, discovered by Dr. Ricardo Moro-Vidal, BioCurex’s chief executive officer [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/biocurex-poised-for-positive-future-based-on-results-otcbocx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A New Spotlight on Diverse Media Group (PINK:DVME.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/a-new-spotlight-on-diverse-media-group-pinkdvme-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/a-new-spotlight-on-diverse-media-group-pinkdvme-pk/#comments</comments>
		<pubDate>Thu, 22 Oct 2009 11:16:37 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=729</guid>
		<description><![CDATA[Diverse Media Group Inc.

(Public, PINK:DVME.PK)
MiV Investments profiles Diverse Media Group (PINK:DVME.PK) which has recently made a 50% acquisition of Celebrities in Action, Inc. which has a joint venture with Stan Lee, and has agreed to sign up for the responsibilities in regards to finding high profile celebrities and athletes for their movie roles. It is [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/a-new-spotlight-on-diverse-media-group-pinkdvme-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>XTend Medical Set to Redefine Cancer Detection With Nanotechnology (PINK:XMDC.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/xtend-medical-set-to-redefine-cancer-detection-with-nanotechnology-pinkxmdc-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/xtend-medical-set-to-redefine-cancer-detection-with-nanotechnology-pinkxmdc-pk/#comments</comments>
		<pubDate>Tue, 20 Oct 2009 11:53:46 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=714</guid>
		<description><![CDATA[XTEND MEDICAL CORP

(Public, PINK:XMDC)

Cancer has quickly become one of the deadliest diseases, causing well over 13% of all human deaths. Cancer rates could further increase by 50% to 15 million new cases in the year 2020, according to the World Cancer Report, the most comprehensive global examination of the disease to date. Due to this [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/xtend-medical-set-to-redefine-cancer-detection-with-nanotechnology-pinkxmdc-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Holiday Season May Bring Renewed Interest in BizAuctions (OTC:BZCN.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/holiday-season-may-bring-renewed-interest-in-bizauctions-otcbzcn-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/holiday-season-may-bring-renewed-interest-in-bizauctions-otcbzcn-pk/#comments</comments>
		<pubDate>Fri, 16 Oct 2009 12:37:39 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=697</guid>
		<description><![CDATA[BizAuctions Inc.
(Public, OTC:BZCN.PK)
As the holiday season fast approaches during one of the most hard hit economic times in recent memory, certain discount companies look to profit and gain recognition, differentiating themselves from the pack. One of these such companies is BizAuctions Inc. (OTC:BZCN.PK), which is quickly gaining momentum in a $60B excess inventory liquidation  market. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/holiday-season-may-bring-renewed-interest-in-bizauctions-otcbzcn-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AVAX Currently Pending Clinical Trials News for its Pipeline (OTC:AVXT.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/avax-currently-pending-clinical-trials-news-for-its-pipeline-otcavxt-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/avax-currently-pending-clinical-trials-news-for-its-pipeline-otcavxt-pk/#comments</comments>
		<pubDate>Wed, 14 Oct 2009 08:25:22 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=683</guid>
		<description><![CDATA[AVAX Technologies, Inc.
(Public, OTC:AVXT.PK)
AVAX Technologies, Inc. has gone through a vast number of ups and downs throughout 2006 to 2007. At this time StocksHaven Investments profiles the company and takes look at what investors may expect within the near future. 

AVAX had a number of expectations to meet in order to sustain ongoing business operations: [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/avax-currently-pending-clinical-trials-news-for-its-pipeline-otcavxt-pk/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>A Renewed Sense of Optimism in Paradigm Medical (OTC:PDMI.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/a-renewed-sense-of-optimism-in-paradigm-medical-otcpdmi-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/a-renewed-sense-of-optimism-in-paradigm-medical-otcpdmi-pk/#comments</comments>
		<pubDate>Tue, 13 Oct 2009 08:45:17 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=677</guid>
		<description><![CDATA[Paradigm Medical Industries, Inc.
(Public, OTC:PDMI.PK)
The Medical device industry has been one of the most successful industries within 2008 and 2009, and 2010 should continue that trend. StocksHaven Investments profiles Paradigm Medical Industries, Inc., a promising company who will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/a-renewed-sense-of-optimism-in-paradigm-medical-otcpdmi-pk/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>FDA Medical Device: Non-Invasive Cervical Cancer Detection (OTC:GTHP)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-medical-device-non-invasive-cervical-cancer-detection-otcgthp/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-medical-device-non-invasive-cervical-cancer-detection-otcgthp/#comments</comments>
		<pubDate>Thu, 08 Oct 2009 06:57:40 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=666</guid>
		<description><![CDATA[Guided Therapeutics, Inc.
(Public, OTC:GTHP)
Guided Therapeutics, Inc. (OTC:GTHP) contains perhaps one of the most promising medical devices aiming for an annual global $1 billion dollar non-invasive cervical cancer market. Now, lets take a look at how it sits alongside the likes of Nephros (OTC:NEPH) and Imaging3 (OTC:IMGG). Their device LightTouch is a powerful and innovative non-invasive [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-medical-device-non-invasive-cervical-cancer-detection-otcgthp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why Soligenix Will be Successful (OTC:SNGX.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/why-soligenix-will-be-successful-otcsngx-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/why-soligenix-will-be-successful-otcsngx-ob/#comments</comments>
		<pubDate>Wed, 07 Oct 2009 04:11:33 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=647</guid>
		<description><![CDATA[Soligenix, Inc.
(Public, OTC:SNGX)

Soligenix truly is a magnificent company, its no wonder the government also favours it so much by pouring in grants and funding. It stands tall amongst the other struggling small cap biotechs, and even after changing its company info from DORB Pharma (OTC:DORB.OB) to Soligenix (OTC:SNGX.OB), it remains ahead of the pack while [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/why-soligenix-will-be-successful-otcsngx-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://www.dorbiopharma.com/audio/rrshq15.mp3" length="20976800" type="audio/mpeg" />
		</item>
		<item>
		<title>FDA Play: Soligenix, Poised for a Stellar Comeback (OTC:SNGX.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-play-soligenix-poised-for-a-stellar-comeback-otcsngx-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-play-soligenix-poised-for-a-stellar-comeback-otcsngx-ob/#comments</comments>
		<pubDate>Fri, 02 Oct 2009 08:23:54 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=639</guid>
		<description><![CDATA[Soligenix, Inc.
(Public, OTC:SNGX)
The past year and a half has come to be known as the rise of the small cap biotechs #8212; Anyone want to contact Steven Spielberg for a movie suggestion? Terminator: Rise of the Machines, oh please. Nothing seems to stand in the way of these once forgotten ghosts, as they are now [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-play-soligenix-poised-for-a-stellar-comeback-otcsngx-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Can American Scientific be the Next Big Thing? (PINK:ASFX)</title>
		<link>http://www.straightstocks.com/stock-watch/can-american-scientific-be-the-next-big-thing-pinkasfx/</link>
		<comments>http://www.straightstocks.com/stock-watch/can-american-scientific-be-the-next-big-thing-pinkasfx/#comments</comments>
		<pubDate>Fri, 02 Oct 2009 05:10:03 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=634</guid>
		<description><![CDATA[American Scientific Resources, Inc.
(Public, PINK:ASFX)
With the recent explosive gains in Spongetech Delivery Systems, investors were left endlessly searching  for that elusive replacement in their investment portfolio, which was quickly becoming nearly impossible to find #8212; then came American Scientific Resources, Inc. (PINK:ASFX). The similarities between the two couldn#8217;t be closer if we had a genie [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/can-american-scientific-be-the-next-big-thing-pinkasfx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Exciting Upcoming 4Q09 for NeoPharm (OTC:NEOL)</title>
		<link>http://www.straightstocks.com/stock-watch/an-exciting-upcoming-4q09-for-neopharm-otcneol/</link>
		<comments>http://www.straightstocks.com/stock-watch/an-exciting-upcoming-4q09-for-neopharm-otcneol/#comments</comments>
		<pubDate>Wed, 30 Sep 2009 06:55:07 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=630</guid>
		<description><![CDATA[NeoPharm, Inc.
(Public, OTC:NEOL)
At first glance, NeoPharm Inc. (OTC:NEOL) seems like just another regular cancer FDA play, however upon closer inspection there are numerous key facts that set it apart, making it a valuable investment option for biotech enthusiasts. Here at StocksHaven Investments, we don#8217;t just like this company #8212; we like it a lot! Firstly, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/an-exciting-upcoming-4q09-for-neopharm-otcneol/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conference Call – avVaa World Health Care Products Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-avvaa-world-health-care-products-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-avvaa-world-health-care-products-inc/#comments</comments>
		<pubDate>Tue, 29 Sep 2009 21:07:23 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=621</guid>
		<description><![CDATA[avVaa World Health Care Products Inc.

(OTC:AVVH)
At approximately 3:00pm EST, 9/29/09, StocksHaven Investments began the call conference scheduled with Founder, Chairman, and CEO of avVaa World Health Care Products Inc., Mr. Jack Farley, whom was also joined by President and COO, Ms. Lorie Campbell-Farley. The basis of the interview was to provide an executive summary, along [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-avvaa-world-health-care-products-inc/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>An Opportunity Amongst Uncertainty (OTC:MCUJ)</title>
		<link>http://www.straightstocks.com/stock-watch/an-opportunity-amongst-uncertainty-otcmcuj/</link>
		<comments>http://www.straightstocks.com/stock-watch/an-opportunity-amongst-uncertainty-otcmcuj/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 02:02:21 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=610</guid>
		<description><![CDATA[Medicure Inc.
(Public, OTC:MCUJ)
We all love that feel good story of a company riddled with uncertainty and financial distress, which bounces back and maximizes its opportunity. Medicure Inc. (OTC:MCUJ) offers just that, and more. A company whose entity and nature had long been forgotten, barely clinging on low volume, yet glistening with potential. A true diamond [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/an-opportunity-amongst-uncertainty-otcmcuj/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>avVaa Conference Call Postponed to 9/29/09 (OTC:AVVH)</title>
		<link>http://www.straightstocks.com/stock-watch/avvaa-conference-call-postponed-to-92909-otcavvh/</link>
		<comments>http://www.straightstocks.com/stock-watch/avvaa-conference-call-postponed-to-92909-otcavvh/#comments</comments>
		<pubDate>Wed, 23 Sep 2009 06:00:57 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=605</guid>
		<description><![CDATA[avVaa World Health Care Products Inc.
(Public, OTC:AVVH)
At this time, StocksHaven Investments would like to announce that the expected 9/23/09 conference call with avVaa Chairman and CEO, Jack Farley has been pushed back to 9/29/09 due to undisclosed personal reasons by Mr. Farley. However, investors have more reason to be excited over waiting the additional six [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/avvaa-conference-call-postponed-to-92909-otcavvh/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Update: Biovest Aims for BLA, not NDA (OTC:BVTI)</title>
		<link>http://www.straightstocks.com/stock-watch/update-biovest-aims-for-bla-not-nda-otcbvti/</link>
		<comments>http://www.straightstocks.com/stock-watch/update-biovest-aims-for-bla-not-nda-otcbvti/#comments</comments>
		<pubDate>Wed, 23 Sep 2009 03:39:51 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=587</guid>
		<description><![CDATA[Biovest International, Inc.
(Public, OTC:BVTI)
Today, on 9/22/09, StocksHaven Investments had the opportunity of speaking to the Investor Relations representative at Biovest International Inc., Douglas W. Calder regarding the recent profile we conducted. A few minor erroneous details were present, and thus we are issuing a company verified update to clarify these issues.
The first problem at hand [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/update-biovest-aims-for-bla-not-nda-otcbvti/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biovest Inches Closer to Cancer Vaccine BLA Filing (OTC:BVTI)</title>
		<link>http://www.straightstocks.com/stock-watch/biovest-inches-closer-to-cancer-vaccine-bla-filing-otcbvti/</link>
		<comments>http://www.straightstocks.com/stock-watch/biovest-inches-closer-to-cancer-vaccine-bla-filing-otcbvti/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 03:50:41 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=567</guid>
		<description><![CDATA[Biovest International, Inc.
(Public, OTC:BVTI)
As individuals in our respective societies, we all abide by a certain  moral standing. However, regardless of your lifestyle, you will adhere to the notion that there is no greater feeling in the world than knowing you are helping fund a company which could potentially save millions of lives, while at [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/biovest-inches-closer-to-cancer-vaccine-bla-filing-otcbvti/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conference Call with avVaa CEO, Jack Farley (OTC:AVVH)</title>
		<link>http://www.straightstocks.com/stock-watch/conference-call-with-avvaa-ceo-jack-farley-otcavvh/</link>
		<comments>http://www.straightstocks.com/stock-watch/conference-call-with-avvaa-ceo-jack-farley-otcavvh/#comments</comments>
		<pubDate>Mon, 21 Sep 2009 05:43:29 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[avVaa World Health Care Products Inc.]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Founder and Lead Investment Analyst]]></category>
		<category><![CDATA[Jack Farley]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[newsletter distribution services]]></category>
		<category><![CDATA[online credit card payment problems]]></category>
		<category><![CDATA[president and director]]></category>
		<category><![CDATA[StocksHaven Investments company]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=557</guid>
		<description><![CDATA[avVaa World Health Care Products Inc.
(Public, OTC:AVVH)
At this time we would like to announce that StocksHaven Investments and avVaa World Health Care Products Inc. have reached an agreement with regards to a six month investor relations contract. This contract includes three articles, two conference calls and ongoing company updates through our newsletter distribution services. Furthermore, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/conference-call-with-avvaa-ceo-jack-farley-otcavvh/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Play: Redefining Breast Cancer Detection (OTC:LLBO)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-play-redefining-breast-cancer-detection-otcllbo/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-play-redefining-breast-cancer-detection-otcllbo/#comments</comments>
		<pubDate>Fri, 18 Sep 2009 04:54:46 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[achieved technology levels]]></category>
		<category><![CDATA[BioElectronics Corp.]]></category>
		<category><![CDATA[Blue channel]]></category>
		<category><![CDATA[breast biopsy products]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[breast cancer detection products]]></category>
		<category><![CDATA[breast cancers]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer detection system]]></category>
		<category><![CDATA[cancer detection;]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[care physician]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[computer software]]></category>
		<category><![CDATA[conventional and digital mammography systems]]></category>
		<category><![CDATA[detection systems]]></category>
		<category><![CDATA[Diagnostic Products]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[health care systems;]]></category>
		<category><![CDATA[Jim Holmes]]></category>
		<category><![CDATA[Lifeline Biotechnologies Inc.]]></category>
		<category><![CDATA[magnetic resonance imaging]]></category>
		<category><![CDATA[magnetic resonance imaging products]]></category>
		<category><![CDATA[medical technology]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[non-breast-specific diagnostic technologies]]></category>
		<category><![CDATA[non-imaging]]></category>
		<category><![CDATA[non-imaging technology]]></category>
		<category><![CDATA[nuclear imaging products]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Peaceful Trading - Vlad Moraru]]></category>
		<category><![CDATA[pharmacogenetic and prognostic testing products]]></category>
		<category><![CDATA[physician]]></category>
		<category><![CDATA[Reno]]></category>
		<category><![CDATA[stage disease]]></category>
		<category><![CDATA[susceptibility testing products]]></category>
		<category><![CDATA[technology advances;]]></category>
		<category><![CDATA[Treat Diseases Inc.]]></category>
		<category><![CDATA[treatment of breast cancer]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[ultrasound]]></category>
		<category><![CDATA[ultrasound products]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[various disease]]></category>
		<category><![CDATA[What am;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=550</guid>
		<description><![CDATA[Lifeline Biotechnologies Inc.
(Public, PINK:LLBO)
With the recent gains in Hard to Treat Diseases Inc. (PINK:HTDS) and BioElectronics Corp. (OTC:BIEL), investors were left hungry for more undervalued, high potential biotech companies #8212; Then came LifeLine Biotechnologies Inc (OTC:LLBO). As technology continues to redefine the modern era of medical advancements, certain companies will stand apart from the rest, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-play-redefining-breast-cancer-detection-otcllbo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Taking Cancer Treatment to a New Level (OTC:PVCT)</title>
		<link>http://www.straightstocks.com/stock-watch/taking-cancer-treatment-to-a-new-level-otcpvct/</link>
		<comments>http://www.straightstocks.com/stock-watch/taking-cancer-treatment-to-a-new-level-otcpvct/#comments</comments>
		<pubDate>Wed, 16 Sep 2009 04:11:03 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actress]]></category>
		<category><![CDATA[American Society of Clinical Oncology;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[and plans to sell]]></category>
		<category><![CDATA[and plans to sell products]]></category>
		<category><![CDATA[Atopic Dermatitis]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Blue channel]]></category>
		<category><![CDATA[Bob Marley;]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer of the skin]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Cybill Shepherd]]></category>
		<category><![CDATA[device systems]]></category>
		<category><![CDATA[Elizabeth Taylor]]></category>
		<category><![CDATA[Eva Cassidy]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[FDA protocol]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Healthcare Industry]]></category>
		<category><![CDATA[invasive products]]></category>
		<category><![CDATA[John F. Thompson]]></category>
		<category><![CDATA[john mccain]]></category>
		<category><![CDATA[lead investigator]]></category>
		<category><![CDATA[Liver Cancer]]></category>
		<category><![CDATA[malignant melanomas]]></category>
		<category><![CDATA[Melanoma]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[Orlando]]></category>
		<category><![CDATA[owned subsidiaries]]></category>
		<category><![CDATA[prescription drug products]]></category>
		<category><![CDATA[Professor]]></category>
		<category><![CDATA[Provectus Biotech Inc.]]></category>
		<category><![CDATA[Provectus Devicetech Inc.]]></category>
		<category><![CDATA[Provectus Imaging Inc. IP]]></category>
		<category><![CDATA[Provectus Pharmaceuticals Inc.]]></category>
		<category><![CDATA[Provectus Pharmatech Inc.]]></category>
		<category><![CDATA[psoriasis]]></category>
		<category><![CDATA[PURE;]]></category>
		<category><![CDATA[PV-10]]></category>
		<category><![CDATA[Ronald Reagan]]></category>
		<category><![CDATA[Sam Donaldson]]></category>
		<category><![CDATA[skin cancer]]></category>
		<category><![CDATA[skin cancers]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[thin tumours]]></category>
		<category><![CDATA[treatment for melanoma]]></category>
		<category><![CDATA[treatment of psoriasis]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[World Health Organization]]></category>
		<category><![CDATA[Xantech Pharmaceuticals Inc.]]></category>
		<category><![CDATA[Yahoo]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=542</guid>
		<description><![CDATA[Provectus Pharmaceuticals, Inc.
(Public, OTC:PVCT)
StocksHaven Investments profiles one of the most exciting up-and-coming anti-cancer companies in the industry, Provectus Pharmaceuticals (OTC:PVCT). They have one of the deepest pipelines of any small cap biotech, focusing on treatments for: Melanoma, Psoriasis, Atopic Dermatitis, Breast Cancer, and Liver Metastasis. With three drugs nearly ready to enter Phase III, including [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/taking-cancer-treatment-to-a-new-level-otcpvct/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Play: Revolutionary Medical Device (OTC:IMGG)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-play-revolutionary-medical-device-otcimgg/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-play-revolutionary-medical-device-otcimgg/#comments</comments>
		<pubDate>Sun, 13 Sep 2009 23:31:11 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3D medical imaging]]></category>
		<category><![CDATA[3D real time images]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[at X]]></category>
		<category><![CDATA[Behavioral]]></category>
		<category><![CDATA[Behavioral Analyst]]></category>
		<category><![CDATA[biomedical engineer]]></category>
		<category><![CDATA[bright CEO]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cardiologist]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Dean Janes;]]></category>
		<category><![CDATA[diagnostic imaging]]></category>
		<category><![CDATA[diagnostic imaging  department]]></category>
		<category><![CDATA[Diagnostic Imaging Systems]]></category>
		<category><![CDATA[diagnostic medical imaging device]]></category>
		<category><![CDATA[digital imaging]]></category>
		<category><![CDATA[disruptive technology]]></category>
		<category><![CDATA[DViS]]></category>
		<category><![CDATA[DViS (Dominion Volumetric Imaging Scanner)]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Freedonia Group]]></category>
		<category><![CDATA[General Electric]]></category>
		<category><![CDATA[healthcare centers]]></category>
		<category><![CDATA[heart attacks;]]></category>
		<category><![CDATA[high-resolution imaging modality]]></category>
		<category><![CDATA[imaging]]></category>
		<category><![CDATA[Imaging3 Inc.]]></category>
		<category><![CDATA[internal injuries]]></category>
		<category><![CDATA[less expensive tools]]></category>
		<category><![CDATA[low-resolution imaging modality]]></category>
		<category><![CDATA[magnetic resonance imaging]]></category>
		<category><![CDATA[Major]]></category>
		<category><![CDATA[medical device manufacturer]]></category>
		<category><![CDATA[medical diagnostic]]></category>
		<category><![CDATA[medical diagnostic imaging market]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[medical imaging device]]></category>
		<category><![CDATA[medical imaging devices]]></category>
		<category><![CDATA[medical imaging equipment market]]></category>
		<category><![CDATA[medical imaging landscape]]></category>
		<category><![CDATA[medical technology]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mri]]></category>
		<category><![CDATA[noninvasive imaging technology]]></category>
		<category><![CDATA[Patient Anatomy Identification & Location Software]]></category>
		<category><![CDATA[Philip Runfeldt]]></category>
		<category><![CDATA[Philips]]></category>
		<category><![CDATA[physician]]></category>
		<category><![CDATA[Professor]]></category>
		<category><![CDATA[Professor Runfeldt]]></category>
		<category><![CDATA[radical medical device]]></category>
		<category><![CDATA[Real Time]]></category>
		<category><![CDATA[real time 3D]]></category>
		<category><![CDATA[real time 3D image]]></category>
		<category><![CDATA[real time 3D imaging]]></category>
		<category><![CDATA[real time references]]></category>
		<category><![CDATA[real-time  tomographic imaging modality]]></category>
		<category><![CDATA[real-time diagnostic medical imaging]]></category>
		<category><![CDATA[Recommendation]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[robotic surgery]]></category>
		<category><![CDATA[Siemens]]></category>
		<category><![CDATA[sports medicine]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[strokes]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[the Dominion]]></category>
		<category><![CDATA[tomography]]></category>
		<category><![CDATA[top Analyst]]></category>
		<category><![CDATA[ultrasound]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[X Ray]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=527</guid>
		<description><![CDATA[Imaging3, Inc.
(Public, OTC:IMGG)
A new and radical medical device from Imaging3 Inc. (OTC:IMGG) is ready to set the standard, and revolutionize the way we look at X-ray, MRI and CT scans. Imaging 3 is currently awaiting FDA approval on their DViS (Dominion Volumetric Imaging Scanner).  Currently, medical imaging is met with challenges of long waits, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-play-revolutionary-medical-device-otcimgg/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
<enclosure url="http://www.imaging3.com/State_of_Company8-19-09.mp3" length="7203862" type="audio/mpeg" />
		</item>
		<item>
		<title>New Pain Treatment Triumphs Morphine (OTC:NPHC)</title>
		<link>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/</link>
		<comments>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 05:52:41 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adrenoleukodystrophy]]></category>
		<category><![CDATA[Adrenomyeloneuropathy;]]></category>
		<category><![CDATA[AMN]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[anticholinergic therapeutic protein products]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[autoimmune disorders]]></category>
		<category><![CDATA[biologic product]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biopharmaceuticals]]></category>
		<category><![CDATA[Biotech Company]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Blue channel]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[covering]]></category>
		<category><![CDATA[covering technologies]]></category>
		<category><![CDATA[cramps]]></category>
		<category><![CDATA[Decision Resources Inc.]]></category>
		<category><![CDATA[designer]]></category>
		<category><![CDATA[Designer Diagnostics Inc.]]></category>
		<category><![CDATA[drug addiction;]]></category>
		<category><![CDATA[drug delivery]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[drug discovery subsidiary;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[HIV technologies]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[joint pain]]></category>
		<category><![CDATA[lower back pain]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[migraines;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Myasthenia gravis]]></category>
		<category><![CDATA[Nanologix Inc.]]></category>
		<category><![CDATA[neck aches]]></category>
		<category><![CDATA[neuralgia]]></category>
		<category><![CDATA[neurological disorder]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[Nutra Pharma Corp.;]]></category>
		<category><![CDATA[Nutra Pharma Inc.]]></category>
		<category><![CDATA[Orange channel]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceutical Products]]></category>
		<category><![CDATA[prized product]]></category>
		<category><![CDATA[ReceptoPharm Inc.]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Rik J Deitsch;]]></category>
		<category><![CDATA[RPI-MN]]></category>
		<category><![CDATA[severe chronic]]></category>
		<category><![CDATA[shared aerosol delivery technology]]></category>
		<category><![CDATA[Should Nutra Pharma Corp.]]></category>
		<category><![CDATA[shoulder pain]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[suggested retail price]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[tuberculosis;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[viral diseases;]]></category>
		<category><![CDATA[Webinar]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=489</guid>
		<description><![CDATA[Nutra Pharma Corp.
(Public, OTC:NPHC)
Step aside Morphine, the new king of chronic pain treatment has entered the building. With Nutra Pharma#8217;s stock rising nearly 2300% year-to-date, its time we see what all the commotion is about. StocksHaven Investments takes a closer look at Nutra Pharma Corp., which believes will begin generating significant revenues within the next [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Muscle Flex Inc: A Rare Investment Opportunity (OTC:MFLI)</title>
		<link>http://www.straightstocks.com/stock-watch/muscle-flex-inc-a-rare-investment-opportunity-otcmfli/</link>
		<comments>http://www.straightstocks.com/stock-watch/muscle-flex-inc-a-rare-investment-opportunity-otcmfli/#comments</comments>
		<pubDate>Thu, 10 Sep 2009 02:05:59 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[active sports]]></category>
		<category><![CDATA[aerobic devices]]></category>
		<category><![CDATA[American Express]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arthur Levitt;]]></category>
		<category><![CDATA[Bear Stearns Western Regional Offices]]></category>
		<category><![CDATA[BUDDY Tablet Caddy]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Canadian Intellectual Property Office;]]></category>
		<category><![CDATA[Cannes;]]></category>
		<category><![CDATA[CBWL]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[chairman and CEO]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[Cloris Leachman]]></category>
		<category><![CDATA[Cnbc]]></category>
		<category><![CDATA[Cohen Independent Research Group;]]></category>
		<category><![CDATA[Companies Board of Directors]]></category>
		<category><![CDATA[Company Founder]]></category>
		<category><![CDATA[Current Market Capital]]></category>
		<category><![CDATA[Danny Alex]]></category>
		<category><![CDATA[direct advertising]]></category>
		<category><![CDATA[direct advertising marketing channel]]></category>
		<category><![CDATA[Emmy Awards]]></category>
		<category><![CDATA[extreme sports]]></category>
		<category><![CDATA[fitness equipment;]]></category>
		<category><![CDATA[Flex]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Founder and CEO]]></category>
		<category><![CDATA[Gavin Keilly]]></category>
		<category><![CDATA[GBK Productions]]></category>
		<category><![CDATA[Grass Roots Research and Distribution Inc]]></category>
		<category><![CDATA[hair removal]]></category>
		<category><![CDATA[home fitness equipment]]></category>
		<category><![CDATA[home fitness product]]></category>
		<category><![CDATA[in-home fitness products]]></category>
		<category><![CDATA[intensified media exposure]]></category>
		<category><![CDATA[International Federation of Body Builders]]></category>
		<category><![CDATA[Joe Fatone]]></category>
		<category><![CDATA[Kevin Sorbo]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[lower priced products]]></category>
		<category><![CDATA[media exposure]]></category>
		<category><![CDATA[Mercanti Group]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Monica Brant]]></category>
		<category><![CDATA[MTV]]></category>
		<category><![CDATA[Muscle Flex Inc.]]></category>
		<category><![CDATA[Muscle Flex™ Home Fitness Unit]]></category>
		<category><![CDATA[natural hair removal products]]></category>
		<category><![CDATA[Nukala]]></category>
		<category><![CDATA[Otc Bulletin Board]]></category>
		<category><![CDATA[Paul Cohen]]></category>
		<category><![CDATA[personal fitness product]]></category>
		<category><![CDATA[potential new products]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Randy Jackson]]></category>
		<category><![CDATA[real life practical solutions]]></category>
		<category><![CDATA[research analyst]]></category>
		<category><![CDATA[safety products]]></category>
		<category><![CDATA[Sanford I. Weill]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[Solomon Smith Barney]]></category>
		<category><![CDATA[Sponge Tech Delivery Systems]]></category>
		<category><![CDATA[Sporting Goods Manufacturers Association]]></category>
		<category><![CDATA[sports equipment]]></category>
		<category><![CDATA[sports industry]]></category>
		<category><![CDATA[The American Music Awards]]></category>
		<category><![CDATA[the Emmy Awards]]></category>
		<category><![CDATA[The Golden Globes]]></category>
		<category><![CDATA[The MTV Music Awards]]></category>
		<category><![CDATA[The Oscars]]></category>
		<category><![CDATA[the Sundance Film Festival]]></category>
		<category><![CDATA[Top Research Analyst]]></category>
		<category><![CDATA[Total Gym]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice President]]></category>
		<category><![CDATA[www.cohenresearch.com]]></category>
		<category><![CDATA[www.GBKProductions.com]]></category>
		<category><![CDATA[www.grassrootsrd.com]]></category>
		<category><![CDATA[www.HoustonProjects.com]]></category>
		<category><![CDATA[www.MagicOnline.com]]></category>
		<category><![CDATA[www.VataBrasil.com]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=476</guid>
		<description><![CDATA[Muscle Flex, Inc 
(Public, OTC:MFLI)
The following article is submitted by a well experienced private investment group(Farseers) members Mr. Nukala and Mr. Sekona closely working with Stockshaven Investments, which conducted a recent conference call with Danny Alex the CEO of Muscle Flex Inc. Mr. Nukala is also a member of Cohen Investment Group, http://www.cohenresearch.com with [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/muscle-flex-inc-a-rare-investment-opportunity-otcmfli/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investing in Gold – Better than Many Kinds of Savings Accounts</title>
		<link>http://www.straightstocks.com/stock-watch/investing-in-gold-%e2%80%93-better-than-many-kinds-of-savings-accounts/</link>
		<comments>http://www.straightstocks.com/stock-watch/investing-in-gold-%e2%80%93-better-than-many-kinds-of-savings-accounts/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 21:38:30 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[investment tool]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[National Payday]]></category>
		<category><![CDATA[online payday lenders]]></category>
		<category><![CDATA[with high standards in both product]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=471</guid>
		<description><![CDATA[In order to facilitate greater savings and increase financial solidity, many consumers have traditionally turned to savings accounts.  There are many different kinds of savings accounts out there that can offer benefits.  However, in the current economic situation, other options might be more appealing than placing your money within one of the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/investing-in-gold-%e2%80%93-better-than-many-kinds-of-savings-accounts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GenVec’s TNFerade Nears NDA Status (NASDAQ:GNVC)</title>
		<link>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/</link>
		<comments>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 06:06:14 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[adenovector delivery]]></category>
		<category><![CDATA[adenovector delivery technology]]></category>
		<category><![CDATA[adenovector technology]]></category>
		<category><![CDATA[adenovector vaccine candidate]]></category>
		<category><![CDATA[adenovirus]]></category>
		<category><![CDATA[Agricultural Research Service]]></category>
		<category><![CDATA[Allergy]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[and Lead Investment Analyst]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[Antigenics Inc.]]></category>
		<category><![CDATA[Apple Inc]]></category>
		<category><![CDATA[Associate Professor]]></category>
		<category><![CDATA[balance disorders]]></category>
		<category><![CDATA[bank of america corp]]></category>
		<category><![CDATA[Barclays]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[care for patients with balance disorders]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[clinical disease]]></category>
		<category><![CDATA[Dendreon Corporation;]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[Douglas J. Swirsky]]></category>
		<category><![CDATA[esophageal cancer]]></category>
		<category><![CDATA[Executive Vice President]]></category>
		<category><![CDATA[Executive Vice President of Research and Development]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[fibrosis;]]></category>
		<category><![CDATA[Food Supply]]></category>
		<category><![CDATA[foot-and-mouth disease]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Gaithersburg;]]></category>
		<category><![CDATA[gene expression]]></category>
		<category><![CDATA[gene therapy]]></category>
		<category><![CDATA[GenVec Inc.]]></category>
		<category><![CDATA[Head And Neck Cancer]]></category>
		<category><![CDATA[hearing loss;]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Laszlo Zsak]]></category>
		<category><![CDATA[lead therapeutic product candidate]]></category>
		<category><![CDATA[locally advanced pancreatic cancer]]></category>
		<category><![CDATA[Major]]></category>
		<category><![CDATA[Malaria]]></category>
		<category><![CDATA[manager]]></category>
		<category><![CDATA[Marvin Grubman]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[meat products]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[multi-purpose products]]></category>
		<category><![CDATA[National Institute of Allergy]]></category>
		<category><![CDATA[National Institute of Allergy and Infectious Diseases of the National Institutes of Health]]></category>
		<category><![CDATA[Naval Medical Research Center]]></category>
		<category><![CDATA[necrosis]]></category>
		<category><![CDATA[Oncologix Inc.]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
		<category><![CDATA[parasitic disease]]></category>
		<category><![CDATA[Patrick Swazy]]></category>
		<category><![CDATA[Paul H. Fischer]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Ph.D.]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Plum Island Animal Disease Center]]></category>
		<category><![CDATA[president and chief executive officer]]></category>
		<category><![CDATA[Professor of Human Oncology]]></category>
		<category><![CDATA[Q1]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[rectal cancer]]></category>
		<category><![CDATA[Researchers of the Livestock Sciences]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Royce Micro]]></category>
		<category><![CDATA[SAIC-Frederick Inc.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[second-generation vaccine candidate]]></category>
		<category><![CDATA[Spartan Micro]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[Steve Jobs]]></category>
		<category><![CDATA[targeted radiation therapy]]></category>
		<category><![CDATA[therapy for locally advanced pancreatic cancer]]></category>
		<category><![CDATA[TherAtoh]]></category>
		<category><![CDATA[TNFerade;]]></category>
		<category><![CDATA[TNFerade™;]]></category>
		<category><![CDATA[transcriptional start site]]></category>
		<category><![CDATA[treatment of inoperable]]></category>
		<category><![CDATA[treatment of locally advanced pancreatic cancer;]]></category>
		<category><![CDATA[treatment of pancreatic cancer]]></category>
		<category><![CDATA[treatment of various cancers;]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[U.S. Department  of Agriculture]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of California at San Francisco]]></category>
		<category><![CDATA[University of California Irvine  Comprehensive Digestive Disease Center]]></category>
		<category><![CDATA[University of Denver]]></category>
		<category><![CDATA[University Of Wisconsin]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[USDA]]></category>
		<category><![CDATA[vaccine candidate]]></category>
		<category><![CDATA[Vaccine Research Center]]></category>
		<category><![CDATA[Vaccine Research Center/National Institute]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Vice President and Chief Financial Officer]]></category>
		<category><![CDATA[Vice President of Research and Development]]></category>
		<category><![CDATA[Wisconsin]]></category>
		<category><![CDATA[Yahoo]]></category>
		<category><![CDATA[yale]]></category>
		<category><![CDATA[Yale University School of Medicine]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=465</guid>
		<description><![CDATA[GenVec, Inc.
(Public, NASDAQ:GNVC)
StocksHaven Investments profiles a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer, and is currently undergoing Phase III trials which are expected to be completed by Q1 2010. In addition to its therapeutic product [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New E-Mailing List, Free Membership</title>
		<link>http://www.straightstocks.com/stock-watch/new-e-mailing-list-free-membership/</link>
		<comments>http://www.straightstocks.com/stock-watch/new-e-mailing-list-free-membership/#comments</comments>
		<pubDate>Fri, 04 Sep 2009 19:59:12 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Founder and Lead Investment Analyst]]></category>
		<category><![CDATA[Lead Investment Analyst]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=447</guid>
		<description><![CDATA[Tired of missing out on StocksHaven Investments#8217; newest picks? Well now you don#8217;t have to worry. We have recently just put together a special distribution list, and best of all #8211; It#8217;s FREE!

Advantages: 

* Receive alerts well before articles are published #38; PR#8217;d
* Company basics #38; fundamentals will be provided
* Speak directly with Founder and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/new-e-mailing-list-free-membership/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three Blockbuster Drugs Seeking NDA (AMEX:AEN)</title>
		<link>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/</link>
		<comments>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/#comments</comments>
		<pubDate>Fri, 04 Sep 2009 06:15:47 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adeona Pharmaceuticals Inc;]]></category>
		<category><![CDATA[Amgen]]></category>
		<category><![CDATA[Avonex]]></category>
		<category><![CDATA[Betaseron]]></category>
		<category><![CDATA[Betaseron®]]></category>
		<category><![CDATA[cardiovascular diseases]]></category>
		<category><![CDATA[care for MS]]></category>
		<category><![CDATA[Cha]]></category>
		<category><![CDATA[Chairman and Chief Executive Officer]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Chief Executive Officer and co-founder]]></category>
		<category><![CDATA[Chief Operating Officer]]></category>
		<category><![CDATA[chronic inflammatory]]></category>
		<category><![CDATA[Co Founder]]></category>
		<category><![CDATA[cognitive impairment]]></category>
		<category><![CDATA[Colwell Clinical Laboratories]]></category>
		<category><![CDATA[Cordex Pharma Inc.]]></category>
		<category><![CDATA[CPA;]]></category>
		<category><![CDATA[Crystal Research Associates]]></category>
		<category><![CDATA[David Newsome]]></category>
		<category><![CDATA[dementia;]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[dnaJP1]]></category>
		<category><![CDATA[drug therapy]]></category>
		<category><![CDATA[Esq   Chairman & Chief Executive Officer]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fibromyalgia]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Hartlab LLC]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[James S. Kuo]]></category>
		<category><![CDATA[Jeffrey J. Kraws]]></category>
		<category><![CDATA[Jeffrey Wolf]]></category>
		<category><![CDATA[leading clinical scientist]]></category>
		<category><![CDATA[legal blindness]]></category>
		<category><![CDATA[M.B.A.]]></category>
		<category><![CDATA[M.S.]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Max Lyon]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[MS therapies]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[National Eye Institute]]></category>
		<category><![CDATA[National MS Society]]></category>
		<category><![CDATA[National Multiple Sclerosis Society]]></category>
		<category><![CDATA[neurodegenerative diseases]]></category>
		<category><![CDATA[Nicholas Stergis]]></category>
		<category><![CDATA[oral therapies]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Post-partum Depression]]></category>
		<category><![CDATA[Postpartum depression]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[progressive disease]]></category>
		<category><![CDATA[reduced vision]]></category>
		<category><![CDATA[relapsing-remitting multiple sclerosis;]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Steve H. Kanzer]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[the American College;]]></category>
		<category><![CDATA[Treatment for Multiple Sclerosis]]></category>
		<category><![CDATA[treatment of MS]]></category>
		<category><![CDATA[treatment of unmet medical diseases]]></category>
		<category><![CDATA[Trimesta™]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice Chairman]]></category>
		<category><![CDATA[Vice Chairman of our board]]></category>
		<category><![CDATA[Vice Chairman of the Board]]></category>
		<category><![CDATA[vice president of business development]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Zinthionein]]></category>
		<category><![CDATA[ZMC]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=432</guid>
		<description><![CDATA[Adeona Pharmaceuticals, Inc. 

(Public, AMEX:AEN)

StocksHaven Investments takes a look at Adeona Pharmaceuticals, Inc. which currently has three blockbuster drugs in phase III, and are coming close to NDA status. The first being Trimesta, which tackles Multiple Sclerosis (MS) and Post-partum Depression. Secondly, Zinthionein, a product seeking treatment for Age Related Macular Degeneration (AMD). Lastly, Oral [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Online Presentation: Breakthrough Treatment Of Pain (OTC:NPHC)</title>
		<link>http://www.straightstocks.com/stock-watch/online-presentation-breakthrough-treatment-of-pain-otcnphc/</link>
		<comments>http://www.straightstocks.com/stock-watch/online-presentation-breakthrough-treatment-of-pain-otcnphc/#comments</comments>
		<pubDate>Wed, 02 Sep 2009 05:32:34 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[acetaminophen]]></category>
		<category><![CDATA[Adrenomyeloneuropathy;]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[chairman and CEO]]></category>
		<category><![CDATA[Cobroxin]]></category>
		<category><![CDATA[designer]]></category>
		<category><![CDATA[Designer Diagnostics Inc.]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Join Nutra Pharma]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Myasthenia gravis]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[Nutra Pharma Corp.;]]></category>
		<category><![CDATA[ongoing chronic]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical Products]]></category>
		<category><![CDATA[ReceptoPharm Inc.]]></category>
		<category><![CDATA[Rik J Deitsch;]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[tuberculosis;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[viral diseases;]]></category>
		<category><![CDATA[way chronic]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=425</guid>
		<description><![CDATA[Nutra Pharma Corp.
(Public, OTC:NPHC)
StocksHaven Investments has confirmed they are set to profile Nutra Pharma Corp. in the coming days, and states that they have also touched base with with Investor Relations in regards to scheduling a tentative conference call with the Chairman and CEO, Rik J Deitsch. Nutra Pharma has recently made waves within the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/online-presentation-breakthrough-treatment-of-pain-otcnphc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three Valuable Patents, Potential FDA Filing (OTC:PWRM)</title>
		<link>http://www.straightstocks.com/stock-watch/three-valuable-patents-potential-fda-filing-otcpwrm/</link>
		<comments>http://www.straightstocks.com/stock-watch/three-valuable-patents-potential-fda-filing-otcpwrm/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 23:15:05 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actual disease]]></category>
		<category><![CDATA[Alan B. Hollingsworth]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[author]]></category>
		<category><![CDATA[Banner Sun Health Research  Institute]]></category>
		<category><![CDATA[BC-SeraPro]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[collector]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[Director of Breast MRI]]></category>
		<category><![CDATA[ductal carcinoma in situ]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Gemologist]]></category>
		<category><![CDATA[Helen R. Park;]]></category>
		<category><![CDATA[Ira L. Goldknopf]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Marwan Sabbagh]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[Medical Director]]></category>
		<category><![CDATA[member]]></category>
		<category><![CDATA[Mercy Cancer]]></category>
		<category><![CDATA[Mercy Cancer Resource Center]]></category>
		<category><![CDATA[Mercy Women’s Center]]></category>
		<category><![CDATA[Michael Sklar]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mri]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[neurodegenerative diseases]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[NuroPro® AD]]></category>
		<category><![CDATA[Oklahoma LLC]]></category>
		<category><![CDATA[Ph.D.]]></category>
		<category><![CDATA[pharmaceutical and diagnostic]]></category>
		<category><![CDATA[potential medical applications]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[President and Chief Scientific Officer]]></category>
		<category><![CDATA[proteomics]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Sun City]]></category>
		<category><![CDATA[the Medical Director of Breast MRI]]></category>
		<category><![CDATA[treatment of breast cancer]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=421</guid>
		<description><![CDATA[Power3 Medical Products, Inc.
(Public, OTC:PWRM)
The following company analysis has been contributed by a StocksHaven Investments affiliate and member, Michael Sklar. He has been studying the markets for several years now with a focus in undiscovered  Bio-Pharm companies.
About
Power3 Medical Products, Inc. (Power3) is primarily engaged in commercializing its intellectual properties in the area of diagnosis [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/three-valuable-patents-potential-fda-filing-otcpwrm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advanced Healing Now Possible (OTC:DSCI)</title>
		<link>http://www.straightstocks.com/stock-watch/advanced-healing-now-possible-otcdsci/</link>
		<comments>http://www.straightstocks.com/stock-watch/advanced-healing-now-possible-otcdsci/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 06:48:43 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[amputation]]></category>
		<category><![CDATA[analog]]></category>
		<category><![CDATA[anti-microbial advanced wound care product]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Clinical Nurse Specialist]]></category>
		<category><![CDATA[Contract Manufacturing Services]]></category>
		<category><![CDATA[Derma Sciences Inc.]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[fungal infection]]></category>
		<category><![CDATA[integrated manufacturer]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[launched wound dressing product]]></category>
		<category><![CDATA[Manhasset]]></category>
		<category><![CDATA[Mary Brennan]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[North Shore Long Island Jewish Hospital]]></category>
		<category><![CDATA[pharmaceutical candidate]]></category>
		<category><![CDATA[private label products]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[Q4]]></category>
		<category><![CDATA[Quick-Med Technologies]]></category>
		<category><![CDATA[Regranex and Shire]]></category>
		<category><![CDATA[Renovo]]></category>
		<category><![CDATA[scar]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[strong novel pharmaceutical candidate]]></category>
		<category><![CDATA[Systagenix]]></category>
		<category><![CDATA[Toronto]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of Southern California]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wound-care products]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=414</guid>
		<description><![CDATA[Derma Sciences, Inc.
(Public, OTC:DSCI)
Derma Sciences is a truly unique and highly undervalued company within the micro-cap biomed space which currently targets a prescription drug market that is about 5x its present market cap. The company is developing a patented topical drug for accelerated healing and scar prevention and newly launched Advanced Wound Care products approaching [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/advanced-healing-now-possible-otcdsci/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lung Cancer Medical Breakthrough (OTC:BMOD)</title>
		<link>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/</link>
		<comments>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/#comments</comments>
		<pubDate>Sun, 23 Aug 2009 01:58:32 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[Albuquerque City Attorney’s Office]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Ampex]]></category>
		<category><![CDATA[Angela Montoya]]></category>
		<category><![CDATA[automated technology]]></category>
		<category><![CDATA[Biomoda Inc.]]></category>
		<category><![CDATA[Biotechnology Associates]]></category>
		<category><![CDATA[Bladder Cancer]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer detection;]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[Cfo]]></category>
		<category><![CDATA[chair]]></category>
		<category><![CDATA[Cleveland]]></category>
		<category><![CDATA[College of Santa Fe]]></category>
		<category><![CDATA[Constance Dorian]]></category>
		<category><![CDATA[Corporate Secretary and Director]]></category>
		<category><![CDATA[Corporate Secretary and Director of Administration]]></category>
		<category><![CDATA[Director of Administration]]></category>
		<category><![CDATA[electronics]]></category>
		<category><![CDATA[electronics engineer]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[executive and entrepreneur]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[General Counsel]]></category>
		<category><![CDATA[Gordon Bennett]]></category>
		<category><![CDATA[Gustave Roussy]]></category>
		<category><![CDATA[insurance billing codes]]></category>
		<category><![CDATA[John Cousins]]></category>
		<category><![CDATA[John J. Cousins]]></category>
		<category><![CDATA[Lab Technician]]></category>
		<category><![CDATA[Los Alamos National Laboratories]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[lung cancers]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[member]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[New England Journal]]></category>
		<category><![CDATA[New Mexico]]></category>
		<category><![CDATA[New Mexico Department of Veterans Services]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Optical Society of America and the New Mexico State Bar]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[Paris]]></category>
		<category><![CDATA[President and a Director]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[prevention for cancer]]></category>
		<category><![CDATA[public company CFO]]></category>
		<category><![CDATA[San Diego State University]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Subsequent product]]></category>
		<category><![CDATA[technology works]]></category>
		<category><![CDATA[the New England Journal of Medicine]]></category>
		<category><![CDATA[Tim Zannes]]></category>
		<category><![CDATA[Treatment Of Cancer]]></category>
		<category><![CDATA[University of California]]></category>
		<category><![CDATA[University of New Mexico]]></category>
		<category><![CDATA[University of North Carolina]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verrity Gershin]]></category>
		<category><![CDATA[Vice President of Technical Operations]]></category>
		<category><![CDATA[Wharton School]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=401</guid>
		<description><![CDATA[Biomoda, Inc.
(Public, OTC:BMOD)
StocksHaven Investments profiles one of the most promising up and coming small cap biotech companies, Biomoda Inc, which has established a medical breakthrough for early lung cancer detection. It is a development-stage company. The Company is an invitro diagnostics company that develops assays, or tests, to detect cancer. These assays are performed in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Giving Birth to a Profitable Company (OTC:IVOB)</title>
		<link>http://www.straightstocks.com/stock-watch/giving-birth-to-a-profitable-company-otcivob/</link>
		<comments>http://www.straightstocks.com/stock-watch/giving-birth-to-a-profitable-company-otcivob/#comments</comments>
		<pubDate>Sat, 22 Aug 2009 19:19:23 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[author]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Emy’s Salsa Aji Distribution Company Inc.]]></category>
		<category><![CDATA[Eric Sebastien]]></category>
		<category><![CDATA[Esposito]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[infertility]]></category>
		<category><![CDATA[INVO Bioscience Inc.;]]></category>
		<category><![CDATA[INVOcell]]></category>
		<category><![CDATA[INVOcell technology]]></category>
		<category><![CDATA[IT engineer]]></category>
		<category><![CDATA[Kathleen Karloff]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Pakistan]]></category>
		<category><![CDATA[Peru]]></category>
		<category><![CDATA[predicate device]]></category>
		<category><![CDATA[South America]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[Twitter]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.klinkoo.com]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=396</guid>
		<description><![CDATA[INVO BioScience Inc
(Public, OTC:IVOB)
The following company analysis has been contributed by a StocksHaven Investments affiliate and member, Eric Sebastien. He is an entrepreneur with solid investment experience totalling fifteen years, and specializes in the small cap bio-tech field.
About
INVO BioScience Inc. (INVO Bioscience), formerly Emy’s Salsa Aji Distribution Company, Inc., is engaged in providing its INVOcell [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/giving-birth-to-a-profitable-company-otcivob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CEO Reaffirms Positive Future Outlook (PINK:SYMW)</title>
		<link>http://www.straightstocks.com/stock-watch/ceo-reaffirms-positive-future-outlook-pinksymw/</link>
		<comments>http://www.straightstocks.com/stock-watch/ceo-reaffirms-positive-future-outlook-pinksymw/#comments</comments>
		<pubDate>Wed, 19 Aug 2009 18:21:48 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=361</guid>
		<description><![CDATA[SymPowerco Corp.
(Public, PINK:SYMW)
StocksHaven Investments Founder and Lead Investment Analyst, Mr. Michael Vlaicu and private investor, Mr. Nukka have engaged in a conversation with SymPowerco Corp CEO, Mr. John Davenport with regards to ongoing current and future business operations. Mr. Davenport shed light on the recently acquired subsidiaries Hoss Motorsports Inc., and Highline Hydrogen Hybrids Inc., [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/ceo-reaffirms-positive-future-outlook-pinksymw/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investment Performance Update</title>
		<link>http://www.straightstocks.com/stock-watch/investment-performance-update/</link>
		<comments>http://www.straightstocks.com/stock-watch/investment-performance-update/#comments</comments>
		<pubDate>Tue, 18 Aug 2009 07:06:51 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[BioElectronics Corp.]]></category>
		<category><![CDATA[electric motor car solutions]]></category>
		<category><![CDATA[Hemispherx Biopharma Inc.;]]></category>
		<category><![CDATA[Highline Hydrogen Hybrids Systems]]></category>
		<category><![CDATA[HOSS Motor Sports]]></category>
		<category><![CDATA[Ludlow Capital Research]]></category>
		<category><![CDATA[managing partner]]></category>
		<category><![CDATA[Mesa Air Group Inc.;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nephros Inc.]]></category>
		<category><![CDATA[PRs]]></category>
		<category><![CDATA[retail volume]]></category>
		<category><![CDATA[Somaxon Pharmaceuticals Inc.]]></category>
		<category><![CDATA[SpongeTech Delivery Systems Inc]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[SymPowerco Corp.]]></category>
		<category><![CDATA[TerreStar Corporation]]></category>
		<category><![CDATA[Tom Bustamante;]]></category>
		<category><![CDATA[Treat Diseases Inc.]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=350</guid>
		<description><![CDATA[At this time, StocksHaven Investments would like to recall and look back at the last few months of equity advice in order to showcase the proven track record. The following is a list of chosen companies which have been nothing short of stellar, giving investors much needed short term and long term gains despite the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/investment-performance-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pain for Pleasure with Javelin Pharmaceuticals (AMEX:JAV)</title>
		<link>http://www.straightstocks.com/stock-watch/pain-for-pleasure-with-javelin-pharmaceuticals-amexjav/</link>
		<comments>http://www.straightstocks.com/stock-watch/pain-for-pleasure-with-javelin-pharmaceuticals-amexjav/#comments</comments>
		<pubDate>Wed, 05 Aug 2009 20:25:22 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[author]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Dyloject]]></category>
		<category><![CDATA[Ereska]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[freelance journalist]]></category>
		<category><![CDATA[Global Industry Analysts Inc.]]></category>
		<category><![CDATA[Javelin]]></category>
		<category><![CDATA[Javelin Pharmaceutical]]></category>
		<category><![CDATA[Javelin Pharmaceuticals Inc.;]]></category>
		<category><![CDATA[Journalist]]></category>
		<category><![CDATA[large-cap pharmaceutical]]></category>
		<category><![CDATA[Martin Driscoll;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nicholas DeCesare]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[pain management]]></category>
		<category><![CDATA[pain management products]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Therabel Pharma]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=346</guid>
		<description><![CDATA[Javelin Pharmaceuticals Inc.
(Public, AMEX:JAV)
The follow article has been submitted to StocksHaven Investments by Nicholas DeCesare, a highly respected investor and journalist within the biopharma realm.
Take one look at a chart of Javelin Pharmaceuticals over the past six months and you will see a stock that has doubled in price but still sits only around $2.00 [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pain-for-pleasure-with-javelin-pharmaceuticals-amexjav/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Uncovering a Diamond in the Rough, SymPower (PINK:SYMW)</title>
		<link>http://www.straightstocks.com/stock-watch/uncovering-a-diamond-in-the-rough-sympower-pinksymw/</link>
		<comments>http://www.straightstocks.com/stock-watch/uncovering-a-diamond-in-the-rough-sympower-pinksymw/#comments</comments>
		<pubDate>Thu, 30 Jul 2009 00:32:29 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advanced power              producer]]></category>
		<category><![CDATA[Battery Technologies]]></category>
		<category><![CDATA[Battery Technology]]></category>
		<category><![CDATA[CAD]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Carleton University in Canada]]></category>
		<category><![CDATA[Centre of Excellence]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Department of Mechanical and Aerospace Engineering]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[electrochemical energy conversion              device]]></category>
		<category><![CDATA[energy              storage medium]]></category>
		<category><![CDATA[energy markets]]></category>
		<category><![CDATA[Energy Situation]]></category>
		<category><![CDATA[FE DMFC]]></category>
		<category><![CDATA[flat-plate alkaline battery technology]]></category>
		<category><![CDATA[Flowing Electrolyte Direct Methanol Fuel Cell technologies]]></category>
		<category><![CDATA[fuel cell]]></category>
		<category><![CDATA[fuel cell technologies]]></category>
		<category><![CDATA[Fuel Cells]]></category>
		<category><![CDATA[golf]]></category>
		<category><![CDATA[Hybrid Power System]]></category>
		<category><![CDATA[Hybrid Power Systems]]></category>
		<category><![CDATA[John Davenport]]></category>
		<category><![CDATA[majority-owned subsidiary;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[oil quantities]]></category>
		<category><![CDATA[Ontario]]></category>
		<category><![CDATA[Ottawa]]></category>
		<category><![CDATA[Polygenic Power Systems Inc.]]></category>
		<category><![CDATA[power applications]]></category>
		<category><![CDATA[power producer]]></category>
		<category><![CDATA[power supply technologies]]></category>
		<category><![CDATA[Quantum]]></category>
		<category><![CDATA[Quantum Fuel Systems Technologies;]]></category>
		<category><![CDATA[rechargeable alkaline battery technology]]></category>
		<category><![CDATA[Stationary Power Supplies]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[submarine systems]]></category>
		<category><![CDATA[sufficient energy]]></category>
		<category><![CDATA[SymPower]]></category>
		<category><![CDATA[SymPowerco]]></category>
		<category><![CDATA[SymPowerco CEO]]></category>
		<category><![CDATA[Toronto]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=335</guid>
		<description><![CDATA[Sympowerco Corp.
(Public, PINK:SYMW)
StocksHaven Investments analyzes one of the most undervalued alternative energy plays, which in the near future may find itself alongside the predominant players within the Fuel Cell #38; Hybrid Power Systems Research #38; Development sector.  SymPowerco is an energy technology company focused            [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/uncovering-a-diamond-in-the-rough-sympower-pinksymw/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Second Time’s a Charm for Somaxon (NASDAQ:SOMX)</title>
		<link>http://www.straightstocks.com/stock-watch/second-time%e2%80%99s-a-charm-for-somaxon-nasdaqsomx/</link>
		<comments>http://www.straightstocks.com/stock-watch/second-time%e2%80%99s-a-charm-for-somaxon-nasdaqsomx/#comments</comments>
		<pubDate>Wed, 22 Jul 2009 06:46:51 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[biomedical pharmaceutical]]></category>
		<category><![CDATA[critical initial physician]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[insomnia]]></category>
		<category><![CDATA[lead product candidate]]></category>
		<category><![CDATA[Michael Jackson]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[National Sleep Foundation]]></category>
		<category><![CDATA[nutritionist]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Silenor]]></category>
		<category><![CDATA[singer]]></category>
		<category><![CDATA[sleep disorders]]></category>
		<category><![CDATA[Somaxon Pharmaceuticals Inc.]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[treatment for insomnia]]></category>
		<category><![CDATA[treatment of insomnia]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=326</guid>
		<description><![CDATA[Somaxon Pharmaceuticals, Inc.
(Public, NASDAQ:SOMX)
StocksHaven Investments profiles one of the most promising biomedical pharmaceutical company involved with a PDUFA with regards to a drug which could quite possibly revolutionize the treatment for insomnia, a condition affecting over 70 million Americans. The company has been making waves the past few months as investors and institutions gain confidence [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/second-time%e2%80%99s-a-charm-for-somaxon-nasdaqsomx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Multiple Paths for Success (PINK:HTDS)</title>
		<link>http://www.straightstocks.com/stock-watch/multiple-paths-for-success-pinkhtds/</link>
		<comments>http://www.straightstocks.com/stock-watch/multiple-paths-for-success-pinkhtds/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 06:48:10 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[active pharmaceutical ingredient]]></category>
		<category><![CDATA[aforementioned technology]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chile]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[China Mellow Hope Inc.]]></category>
		<category><![CDATA[diphtheria]]></category>
		<category><![CDATA[Egypt]]></category>
		<category><![CDATA[escape routers]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Haemophilus]]></category>
		<category><![CDATA[hepatitis C]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[HTDS]]></category>
		<category><![CDATA[Indonesia]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[intellectual property law]]></category>
		<category><![CDATA[medical subsidiaries]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MS (Multiple Sclerosis)]]></category>
		<category><![CDATA[PRNewswire-FirstCall]]></category>
		<category><![CDATA[rabies]]></category>
		<category><![CDATA[ReNuYu Biochem Inc]]></category>
		<category><![CDATA[ReNuYu Biochmem PLC]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[Serbia]]></category>
		<category><![CDATA[shenzhen]]></category>
		<category><![CDATA[Shenzhen Mellow Hope Pharm Industrial Co. Ltd.]]></category>
		<category><![CDATA[Slavica Bio Chem Co.]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Terry Yan]]></category>
		<category><![CDATA[tetanus]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[Treat Diseases Inc.]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[www.htdsmedical.com]]></category>
		<category><![CDATA[www.mellowhope.com]]></category>
		<category><![CDATA[www.slavicabiochem.com]]></category>
		<category><![CDATA[Yunnan Walvax Biotech Co. Ltd]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=316</guid>
		<description><![CDATA[Hard to Treat Diseases, Inc.
(Public, PINK:HTDS)
With the upcoming flu season upon us (considered between October and May with the peak of the season falling between late December and March), StocksHaven Investments highlights one of the most undervalued pink sheet penny biomedical stocks available, which not only tackles influenza treatments, but also many other harmful and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/multiple-paths-for-success-pinkhtds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
